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Summary 
 
Epidemic and sporadic gastroenteritis is an important public health problem in both high-
income and low-income countries. In the last 30 years, several viruses have been identified as 
etiological agents of gastroenteritis in humans. Outbreaks of gastroenteritis may be caused by 
rotaviruses, astroviruses, adenoviruses and the human caliciviruses. The human caliciviruses 
are assigned to two genera, the Norovirus (NV) and Sapovirus (SV). The NV cause illness in 
people of all age groups, whereas the SV predominantly cause illness in children. Epidemic 
viral gastroenteritis or “winter vomiting disease” was described as early as 1929 but it took 
over 40 years to the discovery of the Norwalk virus using immune electron microscopy (IEM) 
in faecal samples in 1972. These specimens were collected during an outbreak of acute 
gastroenteritis which occurred in 1968 in an elementary school in Norwalk, Ohio, USA.  
 
Following an incubation period of approximately 1-2 days, persons infected with NV develop 
the main symptoms of projectile vomiting and diarrhoea, accompanied by rather unspecific 
symptoms like abdominal cramps, muscle pain, headache and in some cases low-grade fever. 
The illness generally is considered mild and self-limiting, with symptoms lasting in the mean 
2-3 days. The potential of the NV to rise outbreaks with attack rates ranging between 30-90% 
is massive. This can be explained mainly by the high infectivity and environmental stability 
and by the facilitated spread of NV either by contaminated fomites (such as food and water) 
and environment, or directly from person-to-person. The faecal-oral route is described to be 
the most common route of transmission. Recent international studies have shown that NV 
infections are the most frequent cause of gastroenteritis in the community regarding the 
endemic and the epidemic situation. These viruses account for an estimated 6% and 11% of 
all infectious intestinal diseases in England and The Netherlands, respectively, and for an 
estimated 23 million cases in the United States each year. In the past ten years, NV-outbreaks 
were increasingly recognised in Switzerland. However, reliable epidemiological data were 
missing due to the fact that NV are not routinely searched for in diagnostic laboratories and 
there is no obligation to report known cases. 
 
For this reason, the Swiss Federal Office of Public Health (SFOPH) launched a series of 
studies for a first epidemiological assessment of the situation of the NV in Switzerland. 
Within this program, several studies (also within the frame of this thesis) were conducted. 
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Three main study designs were used during this thesis: firstly, a NV screening of 
bacteriological-negative tested patient stool samples, secondly, a general practitioner (GP) 
based case-control study on sporadic NV infections and thirdly, a systematic compilation of 
epidemiological information on NV outbreaks from the whole country and the conducting of 
separate outbreak investigations. 
 
The screening for the presence of NV in previously analysed human stool samples at least 
negative for Campylobacter spp., Shigella spp. and Salmonella spp. from July 2001 to July 
2003 revealed that 17.9% (125) of totally 699 stool samples tested positive for NV by RT-
PCR. Additionally, a winter seasonality could be observed within both years under study. The 
highest rate of NV-positives (38.3%) was detected in the first quarter 2002. The time trend of 
the positivity-rate has to be seen in the context of a newly emerged variant of NV thought to 
possess certain characteristics like a higher virulence and/or a higher environmental stability 
than the previous circulating NV. Parallel to the mentioned study, a second screening was 
carried out to assess the importance of NV mix-infections. Only in one specimen of totally 
132 bacteriologically-positive stool samples from gastroenteritis patients NV were detected. 
 
The GP-based case-control study was performed between July 2001 and July 2003 in the 
German speaking part of Switzerland in order to identify risk factors for sporadic NV 
infections. Different transmission modes under study, e.g. the consumption of certain 
foodstuff and mineral waters, displayed no measurable risk association. These findings are 
consistent with person-to-person transmission as the most important route of transmission for 
community-acquired, sporadic NV infection, in that 39% of all patients reported they had had 
contact with ill persons before their illness. The fact that 33% reported contact with ill 
persons, mainly within family groups, after their own illness suggested that a substantial 
proportion of patients were part of family mini-outbreaks. 
 
Between 2001 and 2003, a study was launched to compile actively and systematically NV 
outbreak information, mostly from the German speaking part of the country. In total, 73 NV-
outbreaks were registered. Most affected were closed settings, like nursing homes (34% of all 
outbreaks) and hospitals (25%). Transmission pathways were identified in 74% of the 
outbreaks. In 81% of these cases person-to-person transmission was the primary route of 
infection and on seven occasions (13%), a foodborne transmission was the possible cause. 
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Finally, a broad phylogenetic analysis of the human NV sequences solely and in comparison 
with NV sequences obtained from a recent mineral water study and from an oyster screening 
in Switzerland was conducted. 63 of the 74 (85%) human NV sequences belonged to NV 
Genogroup II and a temporal clustering was observed within the NV sequences, 
corresponding to the described emergence of a new NV Genogroup II variant. The 
phylogenetic comparison revealed that the NV sequences derived from mineral waters were 
highly related and clustered predominantly separate to the human NV sequences. However, 
single human NV sequences were also found within the mineral water clusters. Additionally, 
a temporal correlation between the dates of the stool specimen with the period of bottling of 
the mineral waters was observed. The oyster sequences displayed a far greater variability and 
no specific clustering with either mineral water or human NV sequences was found. 
 
The results from the present studies – together with the findings from earlier Swiss studies in 
the field of the NV – allowed for the first time the generation of an overview on the current 
epidemiological situation of the NV in Switzerland. 
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Zusammenfassung 
 
Das weltweite Auftreten von sporadischen und auch epidemischen Gastroenteritis-
Erkrankungen in den Industrie- und Entwicklungsländer stellt ein ernsthaftes Problem für die 
Öffentliche Gesundheit dar. In den letzten 30 Jahren konnten mehrere virale Gastroenteritis-
Erreger identifiziert werden. So können Ausbrüche durch Rotaviren, Astroviren, Adenoviren 
und durch die humanen Caliciviren verursacht werden. Die letztere Virusgruppe wird in zwei 
Genera unterteilt: Noroviren (Norovirus, NV) und Sapoviren (Sapovirus, SV). An einer NV-
Infektion können Personen jeglichen Alters erkranken, hingegen werden SV-Infektionen vor 
allem bei Kindern beobachtet. 
 
Die in Epidemien auftretende virale Gastroenteritis, auch „Winter Vomiting Disease“ 
genannt, wurde erstmals 1929 beschrieben. Jedoch mussten noch über 40 Jahre verstreichen, 
bis im Jahre 1972 der Norwalk Virus mittels der Immun-Elektronenmikroskopie (IEM) 
dargestellt werden konnte. Jene untersuchten Viren stammten ursprünglich aus einem 
Gastroenteritisausbruch in einer Grundschule in Norwalk (Ohio), USA, aus dem Jahre 1968. 
 
Die ersten Krankheitssymptome einer NV-Infektion treten nach einer Inkubationszeit von ca. 
1-2 Tagen in Erscheinung. Die Hauptsymptome sind explosionsartiges Erbrechen und 
Diarrhö. Diese Leitsymptome werden häufig begleitet durch unspezifische Symptome, wie 
Bauchkrämpfe, Muskel- und Kopfschmerzen und manchmal leicht erhöhte Temperatur. Die 
Erkrankung an sich ist selbstlimitierend und kann als mild eingestuft werden. Nach etwa 2-3 
Tagen lassen die Symptome in den meisten Fällen nach und verschwinden gänzlich. Jedoch 
ist das epidemische Potential der NV massiv und es können Erkrankungsraten von 30-90% 
innerhalb eines Epidemienkollektives verzeichnet werden. Dieser Umstand kann einerseits 
durch die hohe Infektiosität und andererseits durch die grosse Umweltstabilität der NV erklärt 
werden. NV können durch kontaminierte Vektoren, wie Nahrungsmittel und Wasser, via 
kontaminierter Umwelt und vor allem von Person zu Person übertragen werden. Dabei spielt 
die fäkal-orale Übertragungsweise die bedeutendste Rolle. Internationale Studien konnten 
aufzeigen, dass die NV epidemisch, wie auch endemisch, den wichtigsten Gastroenterits-
Erreger darstellen. Schätzungen ergaben, dass etwa 6% aller infektiösen Magen-
Darmerkrankungen in England, respektive etwa 11% in den Niederlanden, den NV 
zugeschrieben werden müssen. In den USA wird vermutet, dass jährlich etwa 23 Mio. 
Personen an einer NV-Infektion leiden. In den letzten 10 Jahren wurde zwar eine steigende 
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Tendenz im Auftreten von NV-Ausbrüchen in der Schweiz festgestellt, jedoch erwies sich die 
epidemiologische Datenlage als ungenügend verlässlich, da einerseits die NV nicht 
routinemässig nachgewiesen werden und andererseits auch keine NV-Meldepflicht in der 
Schweiz besteht. 
 
Um eine erste epidemiologische Einschätzung der Lage der NV in der Schweiz zu 
ermöglichen, wurden mehrere Studien vom Bundesamt für Gesundheit (BAG) lanciert. Im 
Rahmen dieses Programms wurden ebenfalls die vorliegenden epidemiologischen Studien 
durchgeführt, welche hauptsächlich aus den folgenden drei Studientypen bestanden: ein NV-
Screening von bakteriologisch-negativen Patientenstuhlproben, eine auf Allgemeinpraktiker 
basierende Fall-Kontrollstudie mit sporadischen NV-Patienten und einer schweizweiten 
systematischen Erfassung von NV-Ausbruchsdaten mit vereinzelten Abklärungen von NV-
Epidemien. 
 
Das zwischen Juli 2001 und Juli 2003 durchgeführte NV-Screening von Patientenstuhlproben, 
welche zuvor negativ auf Campylobacter spp., Shigella spp. und Salmonella spp. getestet 
wurden, ergab eine NV-Positivitätsrate mittels RT-PCR von 17.9% (125 NV-positive von 
total 699 Stuhlproben). Zusätzlich konnte eine Wintersaisonalität in der Häufigkeit der 
positiven Befunde verzeichnet werden. Die höchste NV-Positivitätsrate (38.3%) wurde im 
ersten Quartal 2002 festgestellt. Der zeitliche Trend in der Häufigkeitsrate entspricht dem 
Auftreten eines neuen Stammes der NV Genogruppe II in Europa. Es wird vermutet, dass 
dieser Stamm im Vergleich zu älteren zirkulierenden NV eine höhere Virulenz und/oder eine 
grössere Umweltstabilität aufweist. Um die Relevanz von möglichen NV Mischinfektionen 
abzuschätzen, wurde ein zweites Screening mit bakteriologisch-positiven Stuhlproben von 
Gastroenteritis-Patienten durchgeführt. NV konnten lediglich in einer von total 132 
bakteriologisch-positiven Patientenstuhlproben NV nachgewiesen werden. 
 
Die auf Allgemeinpraktiker basierende Fall-Kontrollstudie, welche in der Zeit von Juli 2001 
und Juli 2003 in der Deutschschweiz durchgeführt wurde, hatte zum Ziel, Risikofaktoren für 
die Erkrankung an einer sporadischen NV-Gastroenteritis zu identifizieren. Verschiedenen 
untersuchten Übertragungswegen, u.a. die Konsumation gewisser Nahrungsmittel und 
Mineralwasser, konnten keine Risikoassoziation zugeschrieben werden. Diese Resultate sind 
konsistent mit der postulierten Hauptübertragungsroute der Person-zu-Person Übertragung bei 
sporadischen und community-acquired NV-Infektionen. Dies wird gestützt durch die 
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Ergebnisse, dass 39% der NV-Patienten Kontakt zu zuvor erkrankten Personen und 33% der 
Patienten Kontakt zu danach erkrankten Personen, hauptsächlich innerhalb der Familie, 
aufwiesen. Die letzte Patientengruppe weist darauf hin, dass wahrscheinlich ein beträchtlicher 
Teil der NV-Patienten zu familiären Mini-Ausbrüchen gehörten. 
 
Zwischen 2001 und 2003 wurden systematisch Daten über NV-Ausbrüche, vor allem aus der 
Deutschschweiz, gesammelt und ausgewertet. Insgesamt konnten Informationen von 73 
Ausbrüchen zusammengetragen werden. Die meisten Epidemien fanden in geschlossenen 
Settings statt. So wurden die häufigsten Ausbrüche in Altersheimen (34%) und in Spitälern 
(25%) verzeichnet. Der Übertragungsweg konnte in 74% der NV-Ausbrüche identifiziert 
werden. In 81% jener Fälle konnte die Person-zu-Person Übertragung als hauptsächlicher 
Infektionsweg ermittelt werden. Lediglich bei 7 Ausbrüchen (13%) war eine Übertragung via 
mit NV kontaminierte Lebensmittel möglich. 
 
Letztlich wurden die zusammengetragenen NV-Stämme aus den humanen Stuhlproben 
phylogenetisch ausgewertet und ebenfalls mit den NV-Sequenzen, welche aus der kürzlich 
durchgeführten Mineralwasserstudie und dem Austern-Screening stammen, verglichen. 63 der 
74 (85%) humanen NV-Sequenzen konnten der NV Genogruppe II zugeschrieben und 
zeitliche Häufungen der NV-Sequenzen konnte festgestellt werden. Der phylogenetische 
Vergleich der NV-Sequenzen aus Humanproben mit jenen aus den Mineralwässern ergab, 
dass die Mineralwasser-Sequenzen einen hohen Verwandtschaftsgrad aufwiesen und sich 
überwiegend gesondert zu den humanen NV-Sequenzen clustern. Dennoch konnten 
vereinzelte humane NV-Sequenzen in den Mineralwässer-Cluster gefunden werden. 
Zusätzlich wurde eine temporale Korrelation zwischen den Stuhlprobeentnahmedaten mit der 
Abfüllperiode der Mineralwässer gefunden. Die NV-Sequenzen der Austernproben wiesen 
hingegen eine grosse Variabilität auf und zeigten kein Clustering; weder mit den NV-
Sequenzen aus den Mineralwässern, noch mit jenen aus den Humanproben. 
 
Die Ergebnisse dieser Studien – in Kombination mit den Resultaten früherer Untersuchungen 
in der Schweiz – erlaubten es nun zum ersten Mal einen Überblick über die epidemiologische 
Situation der NV in der Schweiz zu generieren. 
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1. Introduction 
 
1.1 Background 
 
Gastroenteritis is one of the most common and, in public health terms, most important 
diseases in man. During the first 5 years of life, every child will contract diarrhoeal disease, 
and with it comes the risk of dehydration and nutritional deficiency (1). Gastroenteritis in 
children in low-income countries is one of the main reasons for child mortality. In high-
income countries, mortality is rare, but it is nonetheless an important cause of morbidity and 
economic cost (1-2). In England and Wales, one out of every five people has a case of 
infectious intestinal disease (IID) annually (3). In The Netherlands, the incidence of 
gastrointestinal diseases was also found to be high, with 283 episodes per 1000 person-years 
(4). The burden of illness is highest in the young and elderly (3). In the last years, Norovirus 
(NV) outbreaks have regularly occurred in Switzerland, in Europe and in the US (5-6). 
Nowadays, NV are considered to be the most common cause for human viral gastroenteritis 
(2).  
 
1.2 Taxonomy and Genetic Classification 
 
Noroviruses (NV) belong to the family of Caliciviridae and include human and animal 
pathogens. They are non-enveloped, positive-sensed, single stranded RNA viruses and the 
virion is about 28-35nm in diameter (7). The family Caliciviridae was recently divided into 
four designated genus: Lagovirus, Vesivirus, Norovirus and Sapovirus (8-9). Unlike the NV 
and sapoviruses (SV), members of the lagoviruses and vesiviruses are principally of 
veterinary importance. Based both on morphology and genome sequence and organisation, 
NV and SV are grouped as separate genera (1). The NV genus branches into at least three 
distinct Genogroups (GGI, GGII and GGIII) based on genetic divergence of the RNA 
polymerase and in the capsid region (Figure 1). GI and GII infect humans and each 
Genogroup includes several genetic clusters, whereas GIII infects pigs and cows (10-11). GGI 
comprises approximately seven clusters including the prototype Norwalk, Southampton and 
Desert Shield reference stains and GGII comprises approximately ten genotypes including the 
Snow Mountain, Toronto, Bristol and Hawaii reference strains (1,10). 
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Figure 1: Unrooted phylogenetic tree of NV Genogroups I to III (GGI-III), modified after 
Ando et al., 2000 (10). Genetic clusters are enclosed by circles or a square. Human pathogenic 
clusters belonging to GGI are enclosed by a dashed circle and clusters belonging to GGII are 
surrounded by closed circles. The GGIII cluster is enclosed by a square. Not all described 
clusters are plotted in the phylogram. The following prototype strains are included: SMV = 
Snow Mountain virus, HV = Hawaii virus, JV = Jena virus, SOV = Southampton virus, NV = 
Norwalk virus, DSV = Desert Shield virus, BV = Bristol virus, LV = Lordsdale virus, TV = 
Toronto virus, MXV = Mexico virus. Dimension of circles and square were randomly chosen. 
 
1.3 Clinical Picture 
 
In the absence of other factors, infections in immunocompetent patients with NV are typically 
mild and self-limiting (1). The onset of illness is abrupt, usually within 12–48 h after exposure 
and the duration of illness is with 12–72 h relatively short (6,12). The main symptoms are 
projectile vomiting and diarrhoea, accompanied by abdominal cramps, nausea, muscle pain, 
headache and sporadic low-grade fever. But it is the high frequency and intensity of projectile 
vomiting that distinguishes NV from other viral and common bacterial enteric pathogens 
(1,6). On very rare occasions, NV infections may be lethal in persons belonging to risk groups 
(e.g. the elderly) due to serious dehydration (2). Further, the underlying health condition of 
NV patients seem to have no influence on the course of disease (13). The shedding of 
infectious virions may occur at least 2-3 days (up to two weeks) subsequent to the ending of 
clinical symptoms (6,11). Patients suffering from NV infection can only be treated supportive, 
mainly by compensation of the fluid loss (2). It is important to note that besides the typical 
NV symptoms, further atypical symptoms (e.g. prolonged or interrupted courses of disease) 
and asymptomatic disease may occur (1,6,11).  
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NV are contracted by humans via the oral route. As acid-stable viruses they pass through the 
stomach; replication is thought to occur in the small intestine (1,11). It was shown that 
individuals with clinical illness exhibit lesions on the small intestinal mucosa. The mucosa 
lining becomes inflamed and absorptive epithelial cells develop an abnormal appearance. 
Within two weeks, however, the small intestine returns to a normal histological appearance 
(1). Although some degree of short-term immunity appears to be present, long-term immunity 
seems not to exist. This circumstance is demonstrated by the high incidence of NV antibodies 
in otherwise healthy adults even though most of them would have been previously infected in 
childhood (1). It has been observed that some persons involved in NV outbreaks did not 
establish the NV illness even if they were exposed heavily to the agent. An explanation for 
this can be found in differences of genetic susceptibility. Variations in the local immune 
response of the intestinal mucosa or a genetic characteristic (e.g. specific receptors, AB0 
histo-blood group type) may explain why some individuals can develop NV illness and others 
cannot (1,11,14). A recent study revealed that antibody is broadly cross-reactive across GGI 
stains, whereas genetically similar GGII strains were shown to be antigenically distinct (15). 
The overall reason for the lack of sustained immunity gained after NV infections could be 
associated with the high diversity within NV strains and Genogroups as a result of the great 
mutation rate of those viruses (6,7,11). 
 
1.4 Diagnosis of Norovirus Infection 
 
Although the syndrome associated with caliciviral gastroenteritis was described in the medical 
literature over 70 years ago (1), the Norwalk virus prototype was discovered in 1972, four 
years after an outbreak of gastroenteritis in an elementary school in the US (Norwalk, Ohio) 
(16). In the following years, NV (besides rota-, astro- and adenoviruses) were increasingly 
recognised as causes of acute gastroenteritis. But the real medical relevance of the NV was 
not acknowledged until the 1990ies (6). An explanation for this can be found in the inability 
to cultivate NV until to date. Further, NV were mostly detected by electron microscopy (EM) 
or by immune electron microscopy (IEM) previous to the establishment of molecular 
detection methods like the polymerase chain reaction (PCR). Under the electron microscope, 
NV can be identified by their characteristic morphology. Approximately 106–107 virus 
particles per ml stool is required for visualisation by EM; therefore, this technique is useful 
only for specimens collected during the early stages of illness when substantial quantities of 
virus are shed (1,11). Thus, the virus can be found by EM in only 10%–20% of faecal 
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specimens collected on days 2 or 3 of illness. IEM can improve the sensitivity of EM by 10- 
to 100-fold. However, the success of the IEM detection is highly dependant on the skill and 
expertise of the microscopist. Furthermore, the virus might be totally masked if a large excess 
of antibody is present, resulting in a false-negative test (11). Immunoassays, like enzyme-
linked immunosorbent assays (ELISA), are showing an increased sensitivity compared to the 
IEM detection methodology, but their use in diagnostic laboratories has been limited by their 
narrow specificity and failure to detect the majority of these genetically diverse viruses (1). A 
recent study could demonstrate that even an improved ELISA system is still not appropriate 
for the detection of NV on a larger scale (17). Therefore, the PCR detection methodology 
(particularly the reverse transcription-polymerase chain reaction, RT-PCR) must still be seen 
as the golden standard (6,17). RT-PCR is able to detect NV up to two weeks after infection 
and possibly longer (1). The sequencing of the RT-PCR amplicons, while expensive and 
labour-intensive, offers the most virological information. Sequences from various strains (e.g. 
human origin and environmental origin) can be compared and may provide an indication 
about possible chains of infection (6). 
 
In Switzerland, NV are still not routinely searched for in diagnostic laboratories. Therefore, 
the ability to detect NV is limited to a few medical diagnostic and cantonal laboratories (6). 
However, NV infections – especially within outbreaks – can be confirmed with a high 
probability by epidemiological profiling. This profiling is based upon the following syndrome 
of the NV-infection and further epidemiological characteristics (6,12,18): The incubation 
period varies between 1-2 days (range: 12-48 hours); main symptoms are vomiting 
(frequently explosive) and diarrhoea (sometimes profuse), partially accompanied by nausea, 
abdominal pain and cramps, muscle pain, headache and sporadic low-grade fever; in analysed 
patient stool samples, pathogenic bacterial and parasitic agents of gastroenteritis are typically 
not detected; secondary cases are typical within NV-outbreaks; more than 50% of patients are 
suffering from vomiting; there are more patients with vomiting than with fever and adolescent 
patients are suffering predominately from vomiting whereas adult patients are suffering 
predominately from diarrhoea. However, this method of profiling cannot be used to confirm a 
certain viral aetiology (e.g. differentiation between NV and SV is not possible), but is a strong 
tool to conduct a fast and first assessment of a NV-suspicious outbreak scenario (6). Table 1 
summarises the key characteristics used for epidemiological profiling in Switzerland. 
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Table 1: Characteristics used for epidemiological profiling of NV-outbreaks in Switzerland. 
 
Symptoms of NV infection 
 
Main symptoms 
 
Possible accompanying symptoms 
 
• Diarrhoea and/or 
 
• Abdominal cramps 
• Vomiting • Muscle pain 
 • Nausea 
 • Headache 
 • (Low-grade) fever 
 
Epidemiological characteristics of NV infections 
 
• No detection of bacterial and parasitic pathogens 
• Description of vomiting: Frequently projectile, noncontrollable,  
>50% of patients with vomiting 
• Secondary cases: Often, typical 
• Incubation period: Approximately 1-2 days (12-48h) 
• Duration of illness: Approximately 2-3 days (12-72h), may be prolonged 
• Ratio vomiting vs. diarrhoea: Children / adolescents: more vomiting than diarrhoea 
Adults: more diarrhoea than vomiting 
 
1.5 Occurrence of Noroviruses in Europe 
 
Community-Based Studies 
A recent study in The Netherlands found that the incidence of infectious gastroenteritis was 
283 cases per 1000 person-years. In the case-control component of the study, viral agents 
accounted for 34% of all cases, with NV the most common viral pathogen, accounting for 
11% of cases. SV were found in 6% of all cases (4). Similar, results from the England’s IID 
study revealed an overall rate of 194 cases per 1000 person-years (3). The rate of NV 
infection was 13 cases per 1000 person-years (6% of all cases) and the rate of SV was 2.2 
cases per 1000 person-years (0.01% of all cases) (1,3). In Finland, a study revealed that in 
toddlers (2 months to 2 years of age) NV were responsible for 20% of cases and SV for 9%. 
Together, NV and SV were found with similar frequency as rotaviruses (19).  
 
Introduction  6 
 
General Practice-Based Studies 
England’s IID study also showed that NV and SV rates, when measured by presentation to a 
general practitioner (GP), correspond to approximately one sixth of all community cases. 
However, there may be a substantial under-representation of community cases since 
institutions where outbreaks may be disproportionately frequent (e.g. residential homes) were 
excluded from the study population (1,3). Nevertheless, 6.5% of the cases presenting to a GP 
tested positive for NV and 1.5% tested positive for SV (20). A comparable GP-based study in 
The Netherlands found NV slightly less frequently (5.0% of cases) and SV were detected in 
2.0% of cases (21).  
 
Surveillance 
A system of general outbreak surveillance for IID in England and Wales has been operated 
from the Communicable Disease Surveillance Centre (CDSC) since 1992. From the year 1992 
to the year 2000, 5'421 general outbreaks of gastroenteritis were registered. Laboratory 
confirmation of NV was recorded for 36% of these outbreaks. Another 14% of all outbreaks 
were suspected of being caused by viral agents (13). Germany has introduced a NV-specific 
reporting system in 2001 (22). In the year 2002, 47'000 cases of NV infection were registered. 
The NV incidence for the year 2002 in Germany was calculated to be 57 cases per 100'000 
persons (23). In England and Wales, Germany, and in The Netherlands, a striking increase in 
NV outbreaks occurred in 2002. This coincided with the emergence of a new predominant NV 
GGII/4 variant (24). A very similar situation could be observed in the US regarding an 
increase in the number of outbreaks and in the occurrence of a new dominant GGII/4 strain 
(25). Overall, the systems of NV surveillance differ substantially within the different 
European countries (26) and therefore overview data is hardly available from these countries. 
In Switzerland, NV are not routinely searched for in diagnostic laboratories and there is no 
obligation to report known cases to date (6), apart from the obligatory reporting of outbreaks 
registered by the cantonal health authorities (Epidemiengesetz SR 818.101). 
 
Seasonality 
Between 1992 and 2000, in England and Wales, NV outbreaks began increasing in September 
and peaked in the months of January, February, and March. Outbreaks in hospitals and 
residential facilities occur more frequently in the 6 months from November to April than the 
rest of the year, but NV outbreaks in other settings displayed no winter peak (13). This 
finding is consistent with the results of a study from the US which examined the pattern of 
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NV disease occurrence in several countries and found that the low point for disease reports for 
both sporadic cases and outbreaks occurred in the summer months (27). The winter 
seasonality was confirmed also by other studies (2,11). 
 
Age Distribution Within Patients 
NV and SV infections can occur at any age. The highest incidence of these infection can be 
found in children under 5 years and, among children, the most common cause of 
gastroenteritis is viral, with NV being at least as frequent as rotavirus (4,19-20). GP data from 
The Netherlands and England suggests that the odds of seeing a doctor because of NV 
infection generally decreases with increasing age (21,28). Unlike SV, NV infection is 
common among adults (4,28). It should be remembered that GP-based studies essentially 
measure consultation rates, not infection rates. Since NV and SV typically cause a fairly mild 
infection, rates derived from GP settings may be inaccurate and biased towards children, who 
may be more likely to consult a doctor (1). Frequenting a doctor is generally associated with 
more severe illness (29). Further, it is well known that nursing homes are considered to be 
settings with a high risk for NV outbreaks, consequently a large number of outbreaks were 
recorded (13,23,25). However, attack rates are only slightly lower among staff than among 
elderly residents (1). In a broad English survey published in 1993, more than 70% of over 
3000 analysed serum specimens were tested positive for recombinant Norwalk virus antibody 
particles (rNV). Antibody prevalence was highest among the middle age and elderly. In the 
age groups older than 30 years, antibody prevalence was >80%. Prevalence was also high 
among infants (up to 6 months) at 75%. This is likely a measure of maternal antibodies, 
reflecting the high seroprevalence among adults. In the 6–11 months age, antibody prevalence 
was 25%, then rising through adolescence and young adulthood (1,30). A very similar pattern 
was found in 1995 in Sweden (antibodies to Norwalk virus) with overall prevalence at 
approximately 80% (1,31). Viruses closely related to the original Norwalk virus are rarely 
found in molecular studies, yet seroprevalence of antibody to Norwalk virus is high (1) 
Antibodies to Southampton virus (another GGI virus), which was in the late 1990ies more 
commonly recognised was found to have a much lower seroprevalence of only 30% (1,32). 
To obtain an up-to-date overview, parallel studies using harmonised assays are needed to 
compare seroprevalence rates across countries (1). 
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1.6 Transmission Routes and Settings 
 
NV exhibit a high stability against various environmental influences and conditions. NV are 
stable at temperatures from -20°C to 60°C and survive relatively high concentration of 
chlorine (up to 10 ppm) and variations in pH-values (11). There is little information about the 
length of environmental stability. Results from an English study revealed that NV may 
survive up to 12 days on a contaminated carpet (33-34). In general, NV transmission occurs 
via the faecal-oral route, following contamination of fomites by stool and vomitus and 
subsequent ingestion of virus particles. NV are highly infective, mainly due to the low 
infectious dose of 10-100 virus particles and their high environmental stability (11). NV cause 
illness and outbreaks through a number of transmission routes including person-to-person, 
foodborne and waterborne routes and environmental contamination. Person-to-person 
transmission has been documented by two routes, faecal–oral and aerosol formation following 
projectile vomiting. (1,6). Because of the aerosolisation, NV particles can be transmitted over 
distances easily exceeding the range of person-to-person transmission (1,6). NV outbreaks 
were often the result of a mixture of more than one mode of transmission (1). 
 
Person-to-Person Transmission 
Overall, the person-to-person spread is the most common mode of transmission in outbreaks 
(1,6,13). The investigation of 1877 NV-outbreaks between 1992 and 2000 in England and 
Wales showed clearly the domination of the person-to-person transmission: in 85% of all 
outbreaks (1’599) this infection route was the cause of outbreak (13). The airborne 
transmission route plays a key role within the person-to-person spread because of the high 
frequency of vomiting and the resultant aerosolisation of particles associated with NV illness 
(1,6). Since respiratory infection has not been found, aerosolised virus must presumably be 
swallowed after inhalation to cause infection (1). 
 
Foodborne Transmission 
Estimates of the relative importance of foodborne transmission of NV vary greatly from 
country to country. In Sweden, 16% of NV outbreaks from 1994 to 1998 were associated with 
food- or waterborne transmission; in the UK food was implicated in 5% of outbreaks from 
1992 to 1999 as were 17% of outbreaks reported in The Netherlands (35). Newer data from 
the examination of 1877 NV-outbreaks between 1992 and 2000 in England and Wales showed 
that the foodborne transmission pathway was effective in 93 outbreaks (5%) and that in 
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further 91 outbreaks (5%) foodborne followed by person-to-person spread in (13). In contrast, 
a study from the US, postulated that 39% of the 348 registered NV outbreaks between 1996 
and 2000 happened due to foodborne infection and only 12% due to person-to-person spread 
(11). Biases in different surveillance systems partly explain the wide variation in estimates of 
the levels of foodborne transmission in NV outbreaks, e.g. in the US, foodborne outbreaks 
were more likely to be reported because surveillance may be focused on detecting foodborne 
outbreaks (1,36). Foodborne vehicles of NV infection are typically one of three forms: 
contaminated shellfish, items contaminated by infected food handlers or fruits/vegetables 
contaminated through irrigation or washing. (1,37). Since NV can probably be destroyed by 
adequate cooking at 90°C for a short time, vehicles contaminated by infected food handlers 
are typically products eaten raw (e.g. salads) or not cooked after handling (e.g. sandwich 
fillings) (1). In many foodborne outbreaks, a food-handler who was ill prior to or during 
preparation of the implicated food can be identified. Furthermore, fruit and vegetables can 
become contaminated by irrigation waters or by washing prior to freezing or by infected food 
handlers involved in harvesting (1). Generally, a wide range of food types were reported as 
vehicles of infection, including oysters, salad vegetables, poultry, red meat, fruit, soups, 
desserts (13). 
 
Waterborne Transmission 
Drinking water can provide a source for outbreaks of viral gastroenteritis in nearly any 
setting. Outbreaks have occurred as a result of contamination of private wells, public wells as 
well as small and large-scale community water systems (1). Waterborne outbreaks with NV 
were shown to be associated with contaminated septic tanks, industrial water system and 
swimming water as well as drinking water worldwide (38). Two waterborne outbreaks 
occurred in 1998 and in 1999 in Switzerland. The first outbreak with 3500 patients was a 
result of a pump failure producing a spill of sewage into the groundwater (39), the second 
outbreak with 1400 cases occurred due to the usage of contaminated and accidentally 
untreated surface water (6). But there is a strong tendency that such outbreaks, at least in 
Switzerland, are most often the result of deficiencies in the infrastructure or in the water 
treatment process (40). Commercial distribution and production of ice was found also to be a 
vector (1,41). Two Swiss studies detected NV sequences in commercially available mineral 
waters, though no cases of NV illness were linked (42-43). 
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Environmental Contamination 
Environmental contamination with NV is a logical consequence regarding the projectile 
vomiting and diarrhoea. Several studies showed that environmental contamination played a 
key role in NV outbreaks. These studies had clearly shown that NV-particles may keep their 
infectivity a long time (33-34,44). On carpets for example, NV particles stay infectious up to 
12 days (33). 
 
Settings of NV Outbreaks 
The cited investigation of 1877 NV-outbreaks between 1992 and 2000 in England and Wales 
showed the following situation: 40% of the outbreaks occurred in hospitals, 39% in 
residential-care facilities, 8% in hotels, 4% in schools, 6% were linked to food outlets and the 
remaining 4% occurred in other settings (13). These proportions were confirmed in a further 
study in the year 2002 for England and Wales (45). Interestingly, one of the most affected 
setting, the hospitals, did not appear in the study from the Centers for Disease Control and 
Prevention (11). As mentioned, this study is probably biased due to over-representation of 
foodborne outbreaks (1,36). 
 
Zoonoses 
NV (and caliciviruses in general) are also important pathogens in animals. However, 
numerous unsuccessful attempts to infect animals as well as cell lines with NV suggests that 
NV and SV are highly species-specific pathogens (1,46). Up to date, no zoonotic transmission 
of NV were found (47). Additional, it could be revealed that the NV strains in animals (calf 
and pig) were genetically distinct to any NV found in people (47). Interspecies transmission, 
if it does occur, is likely to be a very rare event (1). 
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2. Goal and Objectives 
 
2.1 Epidemiological Starting Position 
 
This thesis was set-up in the second half of the year 2000 parallel to the nascent awareness for 
the relevance of NV especially in Great Britain, The Netherlands and in the US. In this period, 
key publications like “Food-related Illness and Death in the US” by Mead et al. in 1999 (1) 
and others from the British “Study of Infectious Intestinal Disease in England”, conducted 
between 1992 and 1996 (2) and from the “International Workshop on Human Calicivirus” 
organised in 1999 (3) were available for the public and for the scientific community. Nested 
within this period, the Cantonal Laboratories Solothurn and Basel-Landschaft, together with 
the Swiss Federal Office of Public Health (SFOPH), realised the gap in the epidemiological 
data concerning the NV situation in Switzerland. Prior to 2001, only sporadic NV outbreak 
information was available. In March 2001, a pilot study was carried out by the Cantonal 
Laboratories Solothurn and Basel-Landschaft. 100 stool samples previously analysed negative 
for enteric bacterial and parasitic pathogens were analysed for the presence of NV and in 44 
specimens (44%) NV were detected (4). As a consequence to the international data on NV 
and in response to the results of the pilot study, several studies were launched by the Cantonal 
Laboratories Basel-Landschaft and Solothurn in mandate of the SFOPH. The aims of these 
studies were firstly the generating of a NV detection methodology and the subsequent 
application of this method on objectives relevant in terms of food safety (5-8) and secondly, 
the gaining of general epidemiological information on the NV situation in Switzerland. 
 
2.2 Goal and Objectives 
 
Based on the use of the newly designed NV RT-PCR detection method (7), which is also the 
recommended method for NV in water samples by the SFOPH in Switzerland (9), the 
following objectives were realised with the overall goal to obtain information for a first-time 
epidemiological assessment of the NV situation in Switzerland. 
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2.2.1 Objectives 
 
I. To determine the frequency of NV-positive RT-PCR results on patient stool samples 
previously tested negative for Campylobacter spp., Shigella spp. and Salmonella spp. and 
optionally diagnosed negative for other gastroenteric pathogens. 
 
II. To accumulate risk information concerning sporadic NV illness. 
 
III. To compile systematically information in respect to the main transmission modes and 
settings within NV-outbreaks. 
 
IV. To perform phylogenetic analyses on obtained human NV strains and to carry out 
phylogenetic comparisons of NV sequence information, derived from human stool 
samples, from mineral waters and from oysters. 
 
2.2.2 Realisation of Objectives 
 
• From July 2001 to July 2003: 
Carrying out of a NV screening of previously bacteriological-negative tested patient stool 
samples in cooperation with the medical diagnostic laboratory Viollier AG. The screening 
was conducted parallel and was partially integrated within the following mentioned case-
control study. Study area: German speaking part of Switzerland.  
 
• From July 2001 to July 2003: 
Conducting of a general practitioner based case-control study on sporadic NV infections 
in cooperation with the medical diagnostic laboratories Viollier AG and Bakteriologisches 
Institut Olten AG. Study area: German speaking part of Switzerland. 
 
• From January 2001 and December 2003: 
Systematic compilation of epidemiological information on NV outbreaks from the whole 
country and conducting of outbreak investigations within the German speaking part of 
Switzerland. All investigations were performed in cooperation with the SFOPH and the 
specific cantonal health authorities. 
 
Goal and objectives  16 
 
2.3 References 
 
1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV 
(1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607-625 
 
2. IID Study Executive (2000) A report of the study of infectious intestinal disease in 
England. The Stationery Office Books, UK 
 
3. Monroe SS, Ando T, Glass RI (eds.) (2000) International Workshop on Human 
Calicivirus. J Infect Dis 181(Suppl 2):S249-S391 
 
4. Baumgartner A. (2001) «Norwalk-like»-Viren (NLV) und Lebensmittel – eine 
Situationsanalyse für die Schweiz. Bulletin SFOPH 46:909-916 
 
5. Beuret C, Kohler D, Lüthi T (2000) Norwalk-like virus sequences detected by reverse 
transcription-polymerase chain reaction in mineral waters imported into or bottled in 
Switzerland. J Food Prot 63:1576-1582 
 
6. Beuret C, Kohler D, Baumgartner A, Lüthi TM (2002) Norwalk-like virus sequences in 
mineral waters: one-year monitoring of three brands. Appl Environ Microbiol 68:1925-
1931 
 
7. Beuret C (2003) A simple method for isolation of enteric viruses (noroviruses and 
enteroviruses) in water. J Virol Methods 107:1-8 
 
8. Beuret C, Baumgartner A, Schluep J (2003) Virus-contaminated oysters: a three-month 
monitoring of oysters imported to Switzerland. Appl Environ Microbiol 69:2292-2297 
 
9. Beuret C, Baumgartner A (2002b) Empfohlenes Verfahren für den Nachweis von 
“Norwalk-like” Viren (NLV) und Enteroviren in Wasser. Mitt Lebensm Hyg 93:91-103 
 
 
Paper 1: Frequency of NV in human stool samples  17 
 
3. Frequency of Norovirus in Stool Samples from Patients with 
Gastrointestinal Symptoms in Switzerland 
 
R. Fretz1,2, L. Herrmann3, A. Christen2, P. Svoboda1, O. Dubuis3, E.H. Viollier3, M. Tanner2, 
A. Baumgartner4* 
 
1 Cantonal Laboratory Basel-Landschaft, 4410 Liestal, Switzerland 
2 Swiss Tropical Institute, 4002 Basel, Switzerland 
3 Viollier AG, 4002 Basel, Switzerland 
4 Swiss Federal Office of Public Health, 3003 Bern, Switzerland 
 
* Corresponding author: 
Dr. Andreas Baumgartner, Swiss Federal Office of Public Health, Division of Food 
Science, 3003 Bern, Switzerland. 
Phone: ++41 31 322 95 82; E-mail: andreas.baumgartner@bag.admin.ch 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper 1: 
 
Frequency of Norovirus in stool samples from patients with gastrointestinal symptoms in 
Switzerland. 
 
Published in: Eur J Clin Microbiol Infect Dis (2005) 24:214–216 
 
Paper 1: Frequency of NV in human stool samples  18 
 
3.1 Abstract 
 
To determine the frequency of sporadic community-acquired Norovirus (NV) infection in the 
German-speaking part of Switzerland, an evaluation of gastroenteritis cases seen in 
physicians’ practices between July 2001 and July 2003 was conducted. A total of 699 stool 
specimens documented to be free of common bacterial pathogens was screened for the 
presence of NV by RT-PCR. NV was detected in 125 (17.9%) of these specimens. In the 
seasonal analysis, the highest rate of NV-positive samples (38.3%) was found between 
January and March 2002. After July 2002, the study was expanded to additionally test for NV 
in stool samples containing a known bacterial pathogen. Among 132 such specimens, NV was 
detected in only one. This suggests that NV mixed-infections are playing a marginal role in 
Switzerland. 
 
3.2 Introduction 
 
Recent international studies have shown that viral infections, especially with noroviruses 
(NV; formerly known as “Norwalk-like viruses”), are the most frequent cause of community-
acquired gastroenteritis in endemic and epidemic situations. These viruses have been reported 
to account for an estimated 6% and 11% of all infectious intestinal diseases in England and 
the Netherlands, respectively [1, 2]. NV are also the most common cause of infectious 
intestinal disease outbreaks in Western Europe and in the USA [1, 3]. Illness is characterized 
by the acute onset of vomiting and diarrhea after an average incubation period of 12–48 h. 
The fecal-oral route is described as the most common route of transmission. NV are 
transmitted either by contaminated vectors (such as food and water) and contaminated 
fomites, or directly from person to person [4]. 
 
In the past 10 years, NV outbreaks have been recognized increasingly in Switzerland. 
However, solid epidemiological data are lacking due to the fact that NV are not routinely 
searched for in diagnostic laboratories and there is no obligation to report known cases. For 
this reason, the Swiss Federal Office of Public Health launched a series of studies to elucidate 
the epidemiology of NV in Switzerland [5]. In the context of this program, the present study 
was conducted between July 2001 and January 2003. 
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3.3 Material and Methods 
 
All stool samples analyzed in this study were obtained from patients in 17 cantons located in 
the German-speaking part of Switzerland. Between July 2001 and July 2003, a total of 699 
stool samples with negative bacteriological test results were screened for the presence of NV. 
In order for stool samples to be included in the analysis, the following criteria had to be met. 
(i) Results of compulsory testing for Campylobacter spp., Shigella spp. and Salmonella spp. 
And any optional tests to detect other gastroenteric pathogens had to be negative. (ii) The 
subject had to be living within the defined study area. (iii) No other family member could be 
included in the study. (iv) The subject had to be between 6 months and 75 years of age. (v) 
The subject could not be suspected of being part of an NV outbreak or of having a nosocomial 
history or having traveled. 
 
Between July 2002 and January 2003, stool samples that tested positive for at least one 
bacterial enteric agent were also screened for the presence of NV. For this part of the study, 
valid stool samples had to meet the following criteria. (i) Each stool sample had to have been 
found positive for at least one enteropathogenic bacterial agent such as Campylobacter spp., 
Salmonella spp., Shigella spp., Aeromonas spp. or Yersinia spp. (ii) The subject had to live 
within the defined study area. (iii) The subject had to be aged 2 years or older. (iv) The 
subject could not have been hospitalized or in a hospital setting as an outpatient at the time of 
sample collection. 
 
The routine analyses for gastrointestinal bacterial pathogens (and optional viral and/or 
parasitic agents) were conducted at the medical diagnostic laboratory Viollier AG, 
Switzerland. The RT-PCR assay used to screen for NV was based on degenerated primers 
located in regions of the RNA polymerase, and the assay was performed at the Cantonal 
Laboratory Basel-Landschaft as described elsewhere [6]. Since the detection method used in 
this study is common in Switzerland, general sequencing of NV-positive RT-PCR products 
was not performed. For quality control, randomly chosen RT-PCR products were sequenced 
and confirmed by comparison with NCBI GenBank. 
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3.4 Results and Discussion 
 
A total of 699 stool samples negative for Campylobacter spp., Shigella spp. and Salmonella 
spp. were tested for the presence of NV from July 2001 to July 2003. Among these specimens 
125 (17.9%) were found to be positive for NV by RT-PCR. This rate of positivity is clearly 
higher than the 6% and 11% rates previously reported for NV among cases of infectious 
intestinal diseases in England and the Netherlands, respectively [1, 2]. The high rate of NV 
positivity we found can most likely be attributed to presence of the recently emerged and 
previously described NV variant, which is probably more virulent or of a higher 
environmental stability than previous NV strains: The emergence of this strain coincided with 
an increase in the incidence of NV outbreaks registered in 2002 in parts of Europe and in the 
USA [7, 8]. 
 
The rates of NV-positive stool samples we detected per canton are presented in Table 1 and 
ranged from 11.4% to 40.7%. This diversity may be explained by the variation in the number 
of stool samples analyzed per canton. 
 
Table 1: Overall rate of NV-positive stool samples per canton. 
 
Cantons 
 
Total number 
of NV-analyses 
 
 
Number of 
NV-positives 
 
 
Argovia (AG) 
 
168 
  
26 
 
(15.5%)
Berne (BE) 128  18 (14.1%)
Basle-Landschaft (BL) 140  20 (14.3%)
Basle-Town (BS) 65  13 (20.0%)
Grisons (GR) 35  4 (11.4%)
Lucerne (LU) 27  11 (40.7%)
Solothurn (SO) 39  6 (15.4%)
Schwyz (SZ) 12  4 (33.3%)
Uri (UR) 21  5 (23.8%)
Zurich (ZH) 30  4 (13.3%)
 
7 other cantons 
 
34  
 
14 
 
- 
 
Total 
 
699  
 
125
 
(17.9%)
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Figure 1 shows the seasonal distribution of the NV-positive findings. A winter seasonality can 
be observed for both years studied. Starting from the assumption that most cases of NV 
infection detected in this study were sporadic due to the inclusion criteria, the described 
winter seasonality accounts for non-outbreak cases. This finding is consistent with the results 
of a study conducted by US-based researchers in which the incidence of NV disease was 
examined in several countries and the low point for disease attributable to both sporadic cases 
and outbreaks was found to occur in the summer months [9]. In our study, a high rate of NV 
detection (38.3%) was recorded between January and March 2002. Increased incidence 
(14.7%) was also noted between October 2002 and March 2003. But this second period of 
augmented activity was relatively moderate compared to the first one. 
 
In the first screening year, from July 2001 to July 2002, 84 of 346 (24.3%) stool samples were 
found to be NV-positive. In the second year, from July 2002 to July 2003, only 41 of 353 
(11.6%) of the samples were NV-positive. This accounts for a remarkable 52.3% drop in the 
rate of NV-positive findings within 2 years. This decrease may indicate that the novel NV 
strain that emerged in 2002 has started to decline. The highest rate of NV-positive results we 
observed was in the first quarter of the year 2002, which corresponds with the previously 
described first appearance of the new NV variant in Europe [7]. 
 
Interestingly, the age structures of the two patient populations (i.e., NV-positive and NV-
negative patients) were not significantly different (p-value 0.186 with the chi-square test). The 
mean age of the NV-positive patients was 32.8 years (SD, 18.8 years; range, 1.0–74.4 years) 
and that of the NV-negative patients was 33.4 years (SD, 18.7 years; range, 1.1–74.3 years). 
The NV-positive group consisted of 64 (51.2%) men and 61 (48.8%) women, and the NV-
negative group included 257 (44.8%) men and 317 (55.2%) women. In accordance with the 
inclusion criteria, certain parts of the population considered at risk for NV infection (e.g., 
babies <6 months and elderly subjects >75 years of age) [10] were not included in the 
screening. Since it is well known that nursing homes and hospitals are considered to be 
settings with a high risk for NV outbreaks and our study excluded subjects older than 75 years 
and those who had been hospitalized, it is likely that the actual incidence of NV in the cantons 
studied is higher than our findings indicate. 
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Figure 1: Seasonal distribution of the 125 (17.9%) NV-positive stool samples detected among 
699 human stool samples negative for Campylobacter spp., Shigella spp. and Salmonella spp. 
 
Among a total of 132 stool samples that tested positive for at least one bacterial pathogen 
(Aeromonas spp., 7; Campylobacter spp., 104; Salmonella spp., 20; Yersinia enterocolitica, 1) 
and were additionally tested for NV, only one was found to be NV positive. Of these 132 
patients, 23 had a history of travel before the first symptoms of disease appeared: 14 (60.9%) 
had traveled within Europe, 8 (34.8%) had traveled outside of Europe, and for one person the 
destination was not provided. One stool sample tested positive for both NV and Salmonella 
enteritidis, and it was obtained from a patient who had traveled to Greece. The mean age of 
these 132 patients was 35.0 years (SD, 20.5 years; range, 1.1–78.8 years) and the gender 
distribution was 69 men and 63 women. 
 
Only a few European studies on gastroenteritis have been conducted in which a broad panel of 
intestinal pathogens was tested using recently developed techniques (e.g., molecular methods, 
ELISA). One population-based prospective study on gastroenteritis in the Netherlands found 
more than one pathogen in 8% of all stool samples studied [2]. Compared to our results, the 
Dutch study showed a higher number of NV infections with multiple pathogens. However, 
discrepancies with our findings may be explained, in part, by the fact that the relevant part of 
our study only included stool samples that were positive for a bacteriological pathogen and 
children under 2 years of age, who are often infected by Cryptosporidium spp. [11] and 
rotaviruses [12], were excluded. 
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Our results suggest that NV are playing a marginal role in sporadic cases of multi-pathogen 
gastrointestinal infections in the German-speaking part of Switzerland. In patients with 
gastrointestinal symptoms in whom no other pathogen was found, NV was detected in a 
sizable percentage (17.9%) of infections, and the incidence was highest during the winter 
months. However, with 24.3% of infections being found from July 2001 to July 2002 and 
11.6% from July 2002 to July 2003, we suspect the relatively high overall incidence was 
attributable to the emergence of a variant NV strain in 2002. 
 
3.5 Acknowledgement 
 
The authors would like to thank J. Grimbichler, Cantonal Laboratory Basel-Landschaft, for 
his support with the NV analysis. The study was fully financed by the Swiss Federal Office of 
Public Health and the Cantonal Laboratory Basel-Landschaft. 
 
3.6 References 
 
1. Lopman BA, Adak GK, Reacher MH, Brown DW (2003) Two epidemiologic patterns of 
norovirus outbreaks: surveillance in England and Wales, 1992-2000. Emerg Infect Dis 
9:71–77 
 
2. de Wit MAS, Koopmans MPG, Kortbeek LM, Wannet WJB, Vinje J, van Leusden F, 
Bartelds AI, van Duynhoven YT (2001) Sensor, a population-based cohort study on 
gastroenteritis in the Netherlands, incidence and etiology. Am J Epidemiol 154:666–674 
 
3. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV 
(1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607–625 
 
4. Centers for Disease Control and Prevention (2001) “Norwalk-like viruses”: public health 
consequences and outbreak management. MMWR Recomm Rep 50(RR-9):1–18 
 
5. Fretz R, Svoboda P, Schmid H, Baumgartner A (2003) Durch Noroviren verursachte 
Gastroenteritis—eine ¨ Ubersicht. Bulletin SFOPH 46:828–833 
 
6. Beuret C (2003) A simple method for isolation of enteric viruses (noroviruses and 
enteroviruses) in water. J Virol Methods 107:1–8 
 
7. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, 
Reacher M, Brown D, Gray J, Iturriza M et al (2004) Increase in viral gastroenteritis 
outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363:682–688 
 
8. Centers for Disease Control and Prevention (2003) Norovirus activity—United States, 
2002. MMWR 52:41–45 
 
9. Mounts AW, Ando T, Koopmans M, Bresee JS, Noel J, Glass RI (2000) Cold weather 
seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis 181(Suppl 
2):S284–S287 
 
Paper 1: Frequency of NV in human stool samples  24 
 
10. Robert Koch Institute (2003) Erkrankungen durch Norwalk-ähnliche Viren (Noroviren). 
Epidemiologisches Bulletin 6:39–43 
 
11. Fretz R, Svoboda P, Ryan UM, Thompson RCA, Tanner M, Baumgartner A (2003) 
Genotyping of Cryptosporidium spp. isolated from human stool samples in Switzerland. 
Epidemiol Infect 131:663–667 
 
12. Lopman BA, Brown DW, Koopmans M (2002) Human caliciviruses in Europe. J Clin 
Virol 24:137–160 
 
 
Paper 2: Risk factors for NV infections  25 
 
4. Risk Factors for Infections with Norovirus Gastrointestinal Illness in 
Switzerland 
 
R. Fretz1,2, P. Svoboda1, D. Schorr3, M. Tanner2, A. Baumgartner4* 
 
1 Cantonal Laboratory Basel-Landschaft, 4410 Liestal, Switzerland 
2 Swiss Tropical Institute, 4002 Basel, Switzerland 
3 Cantonal Surgeon Basel-Landschaft, 4410 Liestal, Switzerland 
4 Swiss Federal Office of Public Health, 3003 Bern, Switzerland 
 
* Corresponding author: 
Dr. Andreas Baumgartner, Swiss Federal Office of Public Health, Division of Food 
Science, 3003 Bern, Switzerland. 
Phone: ++41 31 322 95 82; E-mail: andreas.baumgartner@bag.admin.ch 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper 2: 
 
Risk factors for infections with Norovirus gastrointestinal illness in Switzerland. 
 
Published in: Eur J Clin Microbiol Infect Dis. In press (E-Pub 2005 Apr 16) 
 
Paper 2: Risk factors for NV infections  26 
 
4.1 Abstract 
 
Viral infections, particularly those caused by noroviruses (NV, genus Norovirus), are the most 
common cause of community-acquired gastroenteritis in Europe, with respect to both endemic 
and epidemic occurrence. For the first time, a general practitioner-based case-control study 
was performed between July 2001 and July 2003 in the German-speaking part of Switzerland 
in order to identify risk factors for sporadic NV infections. The consumption of different 
foodstuffs and of bottled mineral water did not show any significant association with the risk 
of NV gastroenteritis, nor was there any significant effect of individual ABO histo-blood 
group or household size on the incidence of NV gastroenteritis. The findings are consistent 
with person-to-person transmission as the most important route of transmission for 
community-acquired, sporadic NV infection, in that 39% of all patients reported they had had 
contact with ill persons before their illness. The fact that 33% reported contact with ill 
persons, mainly within family groups, after their own illness suggested that a substantial 
proportion of patients were part of family mini-outbreaks. 
 
4.2 Introduction 
 
Recent studies have shown that viral infections, especially those with noroviruses (NV) 
(genus name, Norovirus; former name, Norwalk-like viruses ), are the most frequently 
identified cause of infectious intestinal diseases in Western European communities [1, 2]. NV 
account for an estimated 6% and 11% of all infectious intestinal diseases in England and the 
Netherlands [1, 2], respectively, and for an estimated 23 million cases of NV infection in the 
USA each year [3]. The illness is characterised by acute onset of vomiting and diarrhoea, after 
an average incubation period of 12–48 h. The faecal-oral route seems to be the most common 
route of transmission. NV are transmitted either by contaminated fomites (such as food and 
water) or by direct person-to-person contact [4]. In Switzerland, NV are not routinely 
searched for in clinical microbiology laboratories, nor is there an obligation to report 
infections caused by this viral agent within the system of infectious disease surveillance. 
Therefore, a series of studies was launched by the Swiss Federal Office of Public Health 
(SFOPH) in 2001 in order to get an overall view of NV epidemiology in Switzerland [5]. 
 
In this context, a case-control study was performed in the German-speaking part of the 
country with the objective of identifying for the first time risk factors for sporadic NV disease 
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in Switzerland. The potential risk factors investigated were the consumption of different 
foodstuffs, travel history, contact with ill persons, and ABO histo-blood group type. 
 
4.3 Materials and Methods 
 
Study-Area and Study-Population 
The study included patients suffering from gastroenteritis who consulted a medical 
practitioner and subsequently provided stool samples that tested negative for Campylobacter 
spp., Shigella spp., and Salmonella spp. and in which NV were detected. Patients and controls 
were recruited in the following cantons: Appenzell Inner-Rhodes, Appenzell Outer-Rhodes, 
Argovia, Basle-Landschaft, Basle-Town, Berne, Glarus, Grisons, Lucerne, Nidwalden, 
Obwalden, Schaffhausen, Schwyz, Solothurn, St. Gall, Thurgovia, Uri, Zug, and Zurich, all of 
which belong to the German-speaking part of Switzerland. 
 
Study Design and Sampling 
A general-practitioner-based, matched case-control study was performed in the period 
between July 2001 and July 2003. Cases were identified by collaboration with the medical 
laboratories Viollier AG and Bakteriologisches Institut Olten AG. Cases had to fulfil the 
following case definition: (i) episode of diarrhoea and/or vomiting in patients consulting a 
medical practitioner in the study area; (ii) stool sample negative for Campylobacter spp., 
Shigella spp., and Salmonella spp. and optionally diagnosed negative for other gastroenteric 
pathogens; (iii) stool sample positive for NV genogroup I (GGI) or genogroup II (GGII) by 
reverse transcriptase-polymerase chain reaction (RT-PCR); and (iv) residence of patient 
within the defined study area during the period of illness and medical treatment. Only one 
case per family was included in the study. 
 
The following exclusion criteria were applied: (i) babies under the age of 6 months and 
elderly patients above 75 years; (ii) patients with a history of possible nosocomial disease; 
and (iii) patients known to be a part of an NV outbreak. 
 
One control per case was selected through the assistance of each patient (friend/relative 
control). The control had to be someone who had not consulted a medical practitioner for a 
gastrointestinal illness and had not reported any gastrointestinal symptoms in the 1 month 
before completion of the questionnaire. Furthermore, the control had to be of the same sex 
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and had to belong to the same age group as the corresponding case. The age groups were 
defined as 5-year intervals over the range 5–20 years (i.e., 5–10, 11–15, 16–20) and as 10-
year intervals over the range 20–60 years (i.e., 20–29, 30–39, etc.). In addition, the control 
had to live within 10 km of the case. Questionnaires were sent to the cases and controls after 
they had given consent to participate in the study. The self-administered questionnaires for 
cases elicited demographic information and contained questions on the date of onset, the 
nature of symptoms, the date of inquiry, and further factors considered relevant for the disease 
under study, such as consumption of different food items and beverages, travel history, 
contact with ill persons, and ABO histo-blood group type. Copies of questionnaires are 
available upon request. 
 
Data Collection and Analysis 
Returned questionnaires were coded and double-entered into EpiData 3.0 [6]. Descriptive 
analysis was performed with MS Excel 97. Univariate analysis was carried out with the 
statistical software Intercooled Stata 7.0 [7]. Two logistic regression procedures were 
performed: a conditional logistic regression (clogit) for the standard analysis of the matched 
case-control pairs and a random effects logistic regression (xtlogit) as described elsewhere 
[8]. The latter procedure permits the extension of the analysis beyond matched case-control 
pairs and can analyse all the available data, taking into account the unequal chance of 
selection for the subjects included in the study. Power calculations for the analysis of the 
matched case-control pairs were carried out with the statistical software package NCSS 
2000/PASS 2000 [9]. 
 
Microbiological Analysis of Patient Stool Samples 
Analyses of bacteriological pathogens (and of optional viral and/or parasitic agents) were 
conducted by the medical laboratories Viollier AG and the Bakteriologisches Institut Olten 
AG. The NV RT-PCR diagnosis was performed at the Cantonal Laboratory Basel-Landschaft. 
The method used consisted of a genogroup-specific RT-PCR system for the detection of NV 
GG II based on degenerate primers, which are located in highly conserved regions of the 
RNA polymerase and of a second generic RT-PCR system, also based on degenerate primers. 
This combined system was designed for the detection of NV from human stool specimens and 
water samples [10].  
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Single NV RT-PCR products were chosen randomly, sequenced, and analysed in the frame of 
a broader phylogenetic study (manuscript in preparation). 
 
4.4 Results 
 
Descriptive Epidemiology 
Within the study period from July 2001 to July 2003, 143 patients with stools positive for NV 
and negative for Campylobacter spp., Shigella spp., and Salmonella spp. were identified. Of 
these 143 patients, 127 (89%) returned a completed questionnaire and 126 patients met the 
study inclusion criteria. However, an appropriate control person could be found only for 76 
(60%) study subjects. For the matched case-control study (conditional logistic regression), 73 
properly matched case-control pairs (34 male and 39 female pairs) were obtained. Three case-
control pairs had to be excluded because the distance between the places of residence 
exceeded the 10-km radius. These three pairs were only included in the broader analysis with 
the random effects logistic regression. The distribution of nationalities was very similar for 
cases and controls: 92% of the cases and 95% of the controls were Swiss; moreover, the age 
structure did not differ between the two groups. The mean age of cases was 32.7 years 
(median, 34.0 years), with a range of 1.1–69.3 years. The mean age of controls was 33.2 years 
(median, 37.1 years), with a range of 1.3–70.1 years. Likewise, the distribution of these 
characteristics among all 126 cases who participated in the study corresponded well with the 
matched pairs. The mean age of all cases was 32.9 years (median, 33.8 years), with a range of 
1.0–69.3 years. Finally, 90% of all 126 cases were Swiss. 
 
The different factors analysed and considered to be relevant for the disease under study are 
summarised in Tables 1–4. Due to the study design (consent had to be obtained both from the 
patient and his treating general practitioner), a significant delay between the start of the first 
symptoms and the completion of the patient questionnaire resulted. This period averaged 29 
days (median, 24 days). For this reason, the contents of questionnaires were checked and 
verified by telephone in approximately one-third of all cases. 
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Table 1: Frequency of symptoms of NV illness, compiled from all 126 cases. 
 
Symptoms 
 
Number of cases (n = 126) 
 
Diarrhoea 
 
124 
 
(98.4%) 
Vomiting 84 (66.7%) 
Nausea 85 (67.5%) 
Fever(1) 57 (45.2%) 
Headache 45 (35.7%) 
Abdominal cramps 87 (69.0%) 
Other(2) 46 (36.5%) 
 
1 Mean temperature: 38.5°C (range, ±0.6°C) 
2 Other symptoms: dizziness, flatulence, loss of appetite, muscle pain, joint pain 
 
The reported symptoms shown in Table 1 were compiled from all 126 cases and match the 
NV syndrome, which is based on Kaplan s criteria and is used by the SFOPH [5, 11, 12]. The 
mean duration of illness was 7.3 days (SD, 6.2 days; range, 0.25–28 days). 
 
Forty-nine of the 126 (39%) NV cases reported having had contact with persons showing 
symptoms of gastroenteritis within 3 days before the onset of illness, and 42 (33%) cases 
reported such contact within 3 days after the onset of illness (Table 2). Additionally, 71 of the 
126 cases reported absence from work or school due to their illness. A total of 63 of 71 
patients provided information about the duration of absence, which was 4.3 days on average 
(SD, 3.1 days; range, 0.5–14 days). Only 25 of 126 (19.8%) patients reported a history of 
travel within 3 days before the onset of symptoms. Fifteen (60%) of them had travelled 
abroad, while the remaining 10 (40%) had travelled within Switzerland. Thirty-six (29%) 
patients reported having taken part at a mass event (such as parties or military service). In the 
3 days before the onset of illness, 63 of the 126 (50%) patients had eaten meals in restaurants 
or cafeterias. 
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Table 2: Contact to ill persons before and after the own episode of NV gastroenteritis. 
 
Contact to persons with symptoms of AGE(1) 
 
Number of cases (n = 126) 
 
Contact to ill persons before own illness: 
 
49 (38.9%) 
Contact in own family(2) 28 (57%)
Contact at place of work(3) 16 (33%)
Unknown 5 (10%)
Total 49 (100%)
 
 
Contact to ill persons after own illness: 
 
42 (33.3%) 
Contact in own family(2) 32 (76%)
Contact at place of work(3) 4 (10%)
Unknown 6 (14%)
Total 42 (100%)
 
 
1 AGE: Acute Gastroenteritis 2 Within family and relationship 
3 At place of work, in school, in pre-school or kindergarten 
 
Analytical Epidemiology 
The results of the univariate analysis are presented in Tables 3 and 4. The findings of the 
conditional logistic regression (clogit) in Table 3 revealed that no group of the possible risk 
factors under study (consumption of foods and beverages, personal contacts, and ABO 
histoblood group type) was significantly associated with NV gastroenteritis. These results 
were confirmed by the random effects logistic regression (xtlogit), as shown in Table 4. 
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Table 3: Results of the conditional logistic regression (Stata 7.0, clogit) for the analysis of the 
matched case-control pairs. 
 
 
Exposure 
 
Pairs
 
OR(1) 
 
(95% CI) 
 
p(2) 
 
Total 
 
73 
 
- 
 
- 
 
- 
 
Consumed food and beverages: 
Salad 73 1.25 (0.34; 4.65) 0.74 
Raw berries 72 0.75 (0.17; 3.35) 0.71 
Tap water 73 1.33 (0.56; 3.16) 0.51 
Mineral water 73 1.00 (0.46; 2.16) 1.00 
Sweet beverages 71 1.06 (0.55; 2.05) 0.87 
 
Personal contacts: 
Household with children ≤2 years 73 1.00 (0.29; 3.45) 1.00 
Household with children ≤5 years 73 0.75 (0.26; 2.16) 0.59 
Household with children ≤10 years 73 0.75 (0.26; 2.16) 0.59 
Household with persons ≥65 years 73 0.75 (0.17; 3.35) 0.71 
Household with >1 person 72 1.50 (0.53; 4.21) 0.44 
Household with >2 persons 72 0.77 (0.34; 1.75) 0.53 
Household with >3 persons 72 0.71 (0.32; 1.61) 0.53 
Household with >4 persons 72 1.14 (0.41; 3.15) 0.53 
 
ABO histo-blood group type: 
Type A 36 1.34 (0.55; 3.42) 0.49 
Type B 36 0.33 (0.07; 1.65) 0.15 
Type 0 36 1.00 (0.40; 2.52) 0.49 
Type AB 36 1.50 (0.25; 8.98) 0.65 
Type A/AB 36 1.44 (0.62; 3.38) 0.39 
Type B/AB 36 0.63 (0.20; 1.91) 0.40 
 
1 OR: Maximum Likelihood Estimation Odds Ratio 2 p-value: Likelihood Ratio Test 
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Table 4: Results of the random effects logistic regression procedures (Stata 7.0, xtlogit). All 
data has been included, also of those cases with no controls. 
 
 
Exposure 
 
Cases 
 
Controls
 
OR(1) 
 
(95% CI) 
 
p(2) 
 
Total 
 
126 
 
76 
 
- 
 
- 
 
- 
 
Consumed food and beverages:  
Salad 126 76 1.41 (0.41; 4.78) 0.58 
Raw berries 124 76 0.69 (0.17; 2.74) 0.59 
Tap water 126 76 1.01 (0.53; 1.92) 0.98 
Mineral water 124 76 1.15 (0.61; 2.15) 0.67 
Sweet beverages 126 76 1.10 (0.60; 1.99) 0.76 
 
Personal contacts: 
Household with children ≤2 years 126 76 0.89 (0.34; 2.10) 0.79 
Household with children ≤5 years 126 76 0.83 (0.44; 1.55) 0.57 
Household with children ≤10 years 126 76 0.77 (0.43; 1.37) 0.37 
Household with persons ≥65 years 126 76 1.22 (0.40; 3.72) 0.72 
Household with >1 person 125 76 2.18 (0.86; 5.54) 0.10 
Household with >2 persons 125 76 0.87 (0.48; 1.59) 0.65 
Household with >3 persons 125 76 0.91 (0.51; 1.62) 0.75 
Household with >4 persons 125 76 1.25 (0.53; 2.95) 0.61 
 
ABO histo-blood group type:  
Type A 62 45 1.20 (0.55; 2.61) 0.64 
Type B 62 45 0.28 (0.07; 1.13) 0.07 
Type 0 62 45 1.11 (0.51: 2.45) 0.79 
Type AB 62 45 1.89 (0.35; 10.2) 0.46 
Type A/AB 62 45 1.39 (0.64; 3.00) 0.40 
Type B/AB 62 45 0.59 (0.21; 1.70) 0.32 
 
1 OR: Odds Ratio, corrected for random effect 2 p-value: Wald Test 
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4.5 Discussion 
 
The sample size of 73 matched case-control pairs does not allow small risks to be detected 
with reasonably high confidence and power. The conducted power calculations showed that a 
minimal statistically significant odds ratio (OR) of 2.9 ( value 0.05, power of 0.80) can be 
achieved with 70 matched case-control pairs (probability of event in exposed group: 0.5). A 
further limiting factor was the long interval between mailing and return of the questionnaires 
(median, 24 days) that may have introduced a considerable recall bias. The delay can be 
explained by the fact that the NV analysis of the patient stool samples was only performed 
after the return of a negative bacterial culture and after informed consent was obtained from 
both the patient and his general practitioner. This delay may have influenced the information 
on the food and beverages consumed. On the other hand, it probably had less influence on the 
results concerning the personal contacts, certainly within families. 
 
The most important finding of the present study is that 39% of all cases reported contact with 
ill persons before the onset of illness, and 33% reported contact after their own illness (Table 
2). Although no information regarding the contact with ill persons was obtained from the 
control subjects, it can be stated that the contacts previous to illness point to the relevance of 
ill persons as sources of infection, while the contacts following illness are an indication of the 
relevance of the ease of the person-to-person transmission route. Due to the high infectivity 
and simplicity of person-to-person transmission of NV, at least the contacts with ill family 
members are very probably indicative of real chains of infection. This kind of personal 
contact within and outside the family has been shown to be a relevant risk factor in earlier 
studies [13, 14]. A Dutch study has revealed a strong association between NV illness and 
household contacts with gastroenteritis [13]. The large number of contacts with ill persons 
within the family group suggests that a substantial proportion of the patients belonged to 
family mini-outbreaks. However, the comparison of the different household sizes revealed no 
statistically significant effect on NV gastroenteritis. 
 
The results regarding the consumption of bottled mineral water (Tables 3 and 4) are 
interesting in relation to recent findings of NV sequences in different brands of mineral waters 
[15, 16]. The results from this study do not confirm this risk and are in concordance with the 
estimation of the SFOPH that NV-contaminated mineral water does not play a major role in 
the epidemiology of NV in Switzerland [5, 17]. 
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The difference in risk associated with individual ABO histo-blood groups did not show 
statistical significance. Thus, the previous findings regarding a possible correlation between 
the histo-blood group type B (protective) and histo-blood group type O (risk factor) with 
respect to NV infections [18, 19] could not be confirmed in this study. The results must be 
seen in the context of other findings, which show that no general conclusion could be reached 
on the association between the ABO histo-blood group subtypes and the risk of illness, and 
additional histo-blood types, such as Lewis and ABH, seemed to play important roles in the 
probability of disease manifestation [18–22]. Furthermore, our results may be biased by the 
fact that the distribution of ABO histo-blood group types of the control group differs from that 
for Switzerland as a whole (p value, chi-squared xtlogit: 0.046; p value, chi-squared clogit: 
0.005; detailed data not shown). 
 
The reported symptoms of illness (Table 1) matched those of the known NV syndrome [5, 11, 
12]. However, the mean duration of illness of 7.3 days was significantly higher than the 
average duration of NV illness of 12–72 h published in the literature [5, 11]. This may reflect 
the fact that our study only included patients who visited a physician, and hence their illness 
may have been generally more serious than that of NV patients in common-source outbreaks, 
which generally include all cases [23]. The findings on the absence from work indicate that 
sporadic community-acquired NV infections are of substantial economic importance. 
 
In conclusion, the results of this study are consistent with person-to-person transmission being 
of importance for the spread of sporadic community-acquired NV infections, a finding that 
correlates well with the postulated main transmission pathway from person to person within 
confined NV outbreaks [5, 24, 25]. However, due to the limitations outlined, further work is 
necessary to identify all factors and critical points to be considered for prevention and control 
of NV outbreaks. 
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5.1 Summary 
 
Viral infections, especially those with noroviruses are the most common cause of acute 
gastroenteritis in Europe. To obtain information about the epidemic situation of noroviruses in 
Switzerland, an initial study was launched in the German-speaking part of the country to 
systematically compile Norovirus outbreak information between 2001 and 2003. In total, 73 
outbreaks were registered. Most affected were closed settings, e.g. nursing homes (34%) and 
hospitals (25%). Transmission pathways were identified in 74% of Norovirus outbreaks. In 
81% of these cases person-to-person transmission was the primary route of infection and on 
seven occasions (13%), a foodborne transmission was the possible cause. Furthermore, 
Norovirus outbreak characteristics of epidemiological importance are highlighted with a 
discussion of four selected events. 
 
5.2 Introduction 
 
Recent international studies have shown that viral infections, especially those with 
noroviruses (formerly known as Norwalk-like viruses), are the most frequent cause of 
gastroenteritis in the community with regard to the endemic and epidemic situation [1–6]. 
These viruses account for an estimated 6% and 11% of all infectious intestinal diseases in 
England and The Netherlands respectively [3, 5] and for an estimated 23 million cases in the 
United States annually [7]. Noroviruses are also the most common cause of outbreaks of 
infectious intestinal diseases in Western Europe and North America [3, 7]. The illness is 
characterized by acute onset of vomiting and diarrhoea, after an average incubation period of 
12–48 h. The faecal–oral route is described as the most common route of transmission. 
Noroviruses are transmitted either by contaminated fomites (such as food and water) and the 
environment, or directly by person-to-person contact [8]. Noroviruses are often responsible 
for foodborne outbreaks due to contaminated water, ready-to-eat dishes, seafood, fruits and 
vegetables. Furthermore, various outbreaks have been associated with the ingestion of 
contaminated drinking or recreational surface water [9]. During the past 10 years, Norovirus 
outbreaks have been increasingly identified in Switzerland. However, solid epidemiological 
data were missing because noroviruses are not routinely searched for in diagnostic 
laboratories and there is no obligation to report known cases except for outbreaks registered 
by the cantonal (regional) health authorities. For this reason, the Swiss Federal Office of 
Public Health (SFOPH) launched a series of studies to learn more about the national 
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epidemiology of noroviruses [6]. In the context of this programme, systematic investigations 
of outbreaks between 2001 and 2003 were conducted. They are presented and discussed in 
summary with a closer look at four outbreaks of epidemiological importance. 
 
5.3 Methods 
 
Between 2001 and 2003 Norovirus outbreak information was systematically compiled. For 
the purpose of this study, a temporary network consisting of the cantonal (regional) food and 
health authorities (cantonal laboratories and cantonal surgeons) from the German-speaking 
part of Switzerland and the SFOPH was established. Outbreaks of gastrointestinal disease and 
clusters that were suspected of being caused by viral agents were reported by members of this 
network to the Cantonal Laboratory Basel-Landschaft. This institution was in charge of 
registering Norovirus outbreak information from the whole country and conducting separate 
investigations of outbreaks in close cooperation with the health authorities in the German-
speaking part of the country. Switzerland is comprised of 7.4 million inhabitants and the 
German-speaking part accounts for approximately 64% of the country [10]. 
 
Classification of Norovirus outbreaks was performed by descriptive and analytical 
epidemiological investigations, by epidemiological profiling and by laboratory diagnosis. The 
profiling was based upon the Norovirus infection syndrome plus the following additional 
epidemiological characteristics [6, 11, 12]: (i) an incubation period varying between 1–2 days 
(range 12–48 h); (ii) major symptoms of vomiting (frequently explosive) and mainly 
diarrhoea (sometimes profuse), partially accompanied by nausea, abdominal pain and cramps, 
muscle pain, headache and sporadic low-grade fever; (iii) pathogenic bacterial and parasitic 
agents of gastroenteritis typically not detected in analysed patient stool samples; (iv) 
secondary cases typical within Norovirus outbreaks; (v) more than 50% of patients suffering 
from vomiting; (vi) more patients suffer from vomiting than fever, and adolescent patients 
suffer predominately from vomiting whereas adult patients suffer predominately from 
diarrhoea. 
 
Consequently, a Norovirus outbreak was classified as confirmed by exhibiting the typical 
Norovirus profile and by laboratory diagnosis of the pathogen in at least one patient stool 
sample. In a probable Norovirus outbreak, the typical epidemiological profile was present but 
either no patient samples were obtained or the samples were not analysed for the presence of 
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noroviruses. In a possible Norovirus outbreak, either the clinical picture of the persons 
involved was incomplete, or the epidemiological links in terms of place, person and time were 
not established or could not be proven due to lack of information. The transmission routes 
(person-to-person, contaminated water, food or environment) were categorized in analogy to 
the outbreak classification scheme used. 
 
The Norovirus reverse transcription–polymerase chain reaction (RT–PCR) diagnosis was 
performed at the Cantonal Laboratory Basel-Landschaft. The method used consisted of a 
genogroup-specific RT–PCR system for the detection of Norovirus GGII based on degenerate 
primers located in highly conserved regions of the RNA polymerase and of a second generic 
RT–PCR system also based on degenerate primers [13]. Furthermore, this combined system is 
part of the detection method for noroviruses in water samples recommended by the SFOPH in 
Switzerland [14]. 
 
5.4 Results 
 
Overall Characteristics of 73 NV Outbreaks 
Between January 2001 and December 2003, 73 Norovirus outbreaks were analysed. Ninety 
per cent (66/73) of the outbreaks were registered in the German-speaking part of Switzerland 
and a complete epidemiological outbreak investigation was carried out for 20 outbreaks 
(27%). Key information, e.g. primary transmission mode and number of cases, was collected 
from the remaining 53 outbreaks. Six out of 73 outbreaks (8%) were classified as Norovirus 
outbreaks by epidemiological profiling only, without laboratory confirmation. In the 
remaining incidents (92%), noroviruses were detected in patient specimens. 
 
Twenty-five outbreaks (34%) occurred in nursing homes and accommodation for the disabled, 
18 (25%) in hospitals and health resorts, nine (12%) in schools and boy-scout camps, six (8%) 
at social gatherings, five (7%) in hotels, four (5%) in the community, three (4%) in military 
settings, one (1%) at a pilgrimage and two (3%) in other settings. 
 
Transmission pathways were identified in 54 of the 73 outbreaks (74%). In 44 of these 54 
outbreaks (81%), person-to-person transmission was the primary route of infection. On seven 
occasions (13%), a foodborne transmission was a possible cause. One outbreak occurred due 
to an epidemiologically classified probable waterborne incident (discussed below) and 
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another due to a classified possible waterborne episode caused by contamination of the 
drinking water system by sewage leakage. Within the possible foodborne outbreaks, the attack 
rates were high (>70%) and a common meal took place during one incubation period (1–2 
days) before the onset of illness. Epidemiological investigations identified either no 
contaminated foodstuff or insufficient information was available. One large outbreak affected 
different nursing homes and similar institutions during and after a pilgrimage [15]. Generally, 
it could be observed that outbreaks in hospitals, nursing homes and other similar settings 
frequently reflected the current Norovirus situation in the community. Consequently, 
community-acquired and imported Norovirus infections into various settings often acted as 
triggers of outbreaks. In almost all outbreaks with clear person-to-person transmission, the 
Norovirus agent was introduced into the setting by initially ill persons. The mean number of 
cases was found to be 60 (median 35, range 3–650) within all registered outbreaks and attack 
rates ranged between 30% and 90%. 
 
Four selected Norovirus outbreaks will be presented in more detail below, because of their 
inherent characteristics such as transmission mode and setting. 
 
Three Consecutive Outbreaks in Ski Camps 
In January 2001, three consecutive Norovirus outbreaks occurred among ski camps, all 
located in the same accommodation (chalet) in the Swiss mountains. Norovirus infection was 
confirmed by epidemiological profiling and by RT–PCR diagnosis. Only one patient stool 
sample could be collected. The isolated Norovirus strain showed a sequence identity of 88% 
with the strain OS120458/01 (GenBank accession no. AB071035). Twenty-nine out of 34 
persons (85%) were affected in the first ski camp, 21 out of 26 (81%) in the second and 13 out 
of 30 (43%) in the third. The epidemic curve in Figure 1 shows that in the first camp, a point- 
source infection occurred. A foodborne infection seems likely because of the high attack rate 
(85%) and also because the probable time of exposure could be fixed between late afternoon 
and midnight the day preceding onset of symptoms. One common meal (dinner) took place 
during this time period. Within 1.5 days (the average incubation period of noroviruses) after 
moving into the accommodation, the first symptoms occurred in persons from the second 
camp. In all probability the infections were caused by a heavy Norovirus contamination of the 
accommodation. The illness in the first camp started the night before and on the day of 
departure. Therefore, it appears that the toilets and residential rooms were not properly 
cleaned, as 85% of the persons became ill and suffered from heavy vomiting and diarrhoea. 
Paper 3: NV outbreaks  43 
 
The contamination was confirmed by persons of the second camp who reported the smell of 
vomitus and contaminated pillow covers. The computed time of exposure occurred on the first 
night after arriving at the accommodation. The Norovirus cases in the third camp showed a 
completely different pattern and a point-source of infection could be excluded. Nevertheless, 
the first patients of the third camp may have been infected by the environment of the 
accommodation during the day of arrival. The persons of the third camp were informed about 
the gastroenteritis illness in the two previous camps. Disinfectant was used and the toilets and 
kitchen were cleaned. This may explain the different dynamic of the outbreak that is typical 
for person-to-person transmission. After the guests’ departure from the third camp the 
establishment was shut down and cleaned professionally before reopening. Since the re-
opening no further cases have occurred. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Epidemic curve of three consecutive Norovirus outbreaks in ski camps in January 
2001, located at the same accommodation. Each division on the x-axis describes a time 
interval of 8 h. The position of the date illustrates the first time interval from 0 to 8 h. The 
probable time of exposure in the first and second camp was computed by subtracting the 
maximal incubation period of the noroviruses of 2 days from the last case and subtracting the 
minimal incubation period of 1 day from the first case. The overlapping time period 
corresponds to the probable time of exposure. 
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Outbreak within Two Communities 
Within two weeks in January 2001, two communities were affected by a large outbreak with 
more than 650 cases. Norovirus illness was confirmed by epidemiological profiling and by 
Norovirus RT–PCR on patient stool samples. The two communities were mainly supplied 
with drinking water from a waterworks that distributes purified and processed water from a 
nearby lake. During 8 days within the 2-week outbreak, the water treatment plant in the 
waterworks exhibited major deficiencies regarding the application of chlorine and/or ozone. 
Two samples were drawn on the last day and following treatment failure. The samples neither 
exceeded the official bacteriological criteria for drinking water, nor were noroviruses detected 
by RT–PCR. However, there is evidence that Swiss surface waters are generally contaminated 
with noroviruses [6]. For an estimation of the number of cases, a selection of general 
practitioners, nursing homes and schools within the two communities were questioned and the 
extracted numbers of patients were then extrapolated to the whole population of the two 
communities. Parallel investigations of the local pharmacies supported the estimation. Eight 
patient stool samples were found to be Norovirus-positive by RT–PCR and seven RT–PCR 
products were sequenced. Three samples showed a sequence identity of 89.7% with the 
Norwalk virus (GenBank accession no. NC_001959.1), three samples showed a sequence 
identity of 88.0% with the Camberwell virus strain (NC_002614.1) and the last sample 
exhibited an identity of 98.0% to the Whiterose virus strain (HCA277610). This high variety 
within the discovered Norovirus isolates clearly supports the hypothesis of drinking water as 
the source of the outbreak. 
 
Outbreak Following a Banquet 
In a small outbreak, at a family gathering, 21 out of 25 persons (84%) were found to be 
suffering from gastroenteritis approximately 1.5 days (the average incubation period of 
noroviruses) following a banquet. Norovirus was confirmed by epidemiological profiling and 
by Norovirus RT–PCR on two patient stool samples. One Norovirus isolate was sequenced 
and showed a sequence identity of 94% with Chiba virus (GenBank accession no. 
NC_002613). A cohort study on the consumed food items could not define any foodstuff as a 
risk factor. Because of the low statistical power of the analysis due to the high attack rate and 
small size of the cohort, the foodborne route of infection cannot be excluded. However, the 
food was delivered to the banquet by a catering service. Investigations with the catering 
company showed that no further cases could be found within their clientele. Further 
investigations revealed that the Norovirus agent was most probably introduced into the setting 
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by a young girl from family A (probable time of exposure III). The further transmission 
pathway from the girl to the other guests at the banquet, e.g. by personal contact or by 
contamination of some food items, remained unclear. Looking back at the chain of infection, 
it could be seen that the brother of the young girl was suffering from Norovirus illness 3 days 
previously. Two days before, two ill children of family B had been looked after by the parents 
of the boy and girl (probable time of exposure II). The mother of family B had been 
incapacitated with gastroenteritis 24 h earlier. Finally, this mother was herself visiting a third 
family with an ill boy (probable time of exposure I). All cases were classified as probable 
Norovirus by epidemiological investigation (see Fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Epidemic curve of an outbreak following a banquet in June 2001. Each division on 
the x-axis describes a time interval of 8 h. The position of the date illustrates the first time 
interval from 0 to 8 h. The three different probable times of exposure (I–III) are indicated by 
hatched bars. See text for further explanation of the introduction and transmission of 
noroviruses. 
 
Consecutive NV Outbreaks in a Hospital with an Affiliated Nursing Home 
Between the end of January and the beginning of April 2003, a series of Norovirus cases 
occurred in a Swiss hospital and an affiliated nursing home. In total, 140 persons were 
affected by gastroenteritis : 34 patients from the hospital, 28 patients from the nursing home 
and 78 staff members. Twelve patient stool samples tested positive for Norovirus by RT–
PCR. The epidemic curve with information from 132 patients is plotted in Figure 3. 
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Obviously, the curve is divided into three separate peaks. The Norovirus cases within the 
second and third peak were confirmed by laboratory results, whereas the cases from the first 
peak were classified as probable Norovirus cases by epidemiological profiling only. It is of 
interest that the incident consisted of three separate outbreaks rather than a single protracted 
one. From the 140 patients involved, 132 could be clearly allocated to the hospital, 
respectively to the nursing home. The 28 Norovirus cases (21% out of the 132 patients) 
allocated from the first peak originated exclusively from the hospital and the second peak 
consisted of 29 patients (22%) from the hospital and six patients from the nursing home (5%). 
Finally, the last peak was dominated by 48 patients (36%) from the nursing home and also 
included 21 patients (16%) from the hospital. The 12 Norovirus-positive stool samples all 
exhibited a sequence identity of 95% with the Norovirus strain Miami Beach (GenBank 
accession no. AF414424). Phylogenetic analyses, conducted with the software packages 
Clustal W, Phylip 3.6a3 and Emboss matcher 2.0u4, revealed that the Norovirus sequences 
discovered formed two separate clusters as shown in Figure 4. The division of the Norovirus 
sequences into the two clusters corresponded exactly to a local distribution of the patients. All 
Norovirus isolates of cluster I originated from patients from the second peak, whereas all 
isolates from cluster II came from patients from the third outbreak peak. The sequences within 
cluster I exhibited an average sequence identity of 100%, whereas the sequences within 
cluster II showed an average identity of 99.9%. The computed sequence identity between 
ID01 (cluster I) and ID10 (cluster II) was 97.9%. The predominant transmission mode in all 
three consecutive outbreaks was the person-to-person route. No information about the entry 
pathway of the noroviruses could be obtained. At the time of the outbreak, community-
acquired Norovirus infections were reported and may have played an important role in 
transporting the agent into the hospital setting. Sequence information of the noroviruses from 
each cluster (ID01 and ID10) was submitted to GenBank (GenBank accession nos. AY551087 
and AY551088). 
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Figure 4: UPGMA tree (Kimura matrix) showing the phylogenetic relationship between 
Norovirus sequences from patient stool samples (IDs) compared to the following reference 
strains: Camberwell virus (CAV; AF145896), Hawaii virus (HV; U07611), Lordsdale virus 
(LV; X86557) and the used positive control (Pos.). The Norovirus sequences of clusters I and 
II are allocated to the second peak (23 February to 7 March), and the third peak (11 March to 
10 April) respectively of the epidemic curve as displayed in Figure 3. 
 
5.5 Discussion 
 
Between the years 2001 and 2003, 73 Norovirus outbreaks were registered by the study 
network consisting of cantonal food and health authorities and SFOPH. This figure will 
certainly not account for the real number of outbreaks during this time period in Switzerland, 
because first, 90% (66/73) of the outbreaks were registered in the German-speaking part of 
Switzerland due to the study design and second, because of the lack of an established 
nationwide reporting system for Norovirus infections. Germany, for example, has operated 
such a reporting system since 2001 [16]. Prior to 2001, only very rudimentary Norovirus 
outbreak data from Switzerland were available. Furthermore, within this period foodborne 
transmission was thought to be the dominant transmission pathway [8]. From the total 156 
registered foodborne outbreaks in Switzerland in the six years from 1993 to 1998, only 25 
(16%) were confirmed or possible Norovirus infections [17]. In England & Wales, Germany, 
and The Netherlands, a striking increase in Norovirus outbreaks occurred in 2002. This 
coincided with the detection and emergence of a new predominant Norovirus GGII variant 
[18]. This emergence of a new strain can most probably be used to explain the high number of 
registered outbreaks presented in this study. 
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With respect to settings, the registered outbreaks occurred predominantly in nursing homes 
(34%), hospitals (25%), camps (12%) and hotels (7%). The investigation of 1877 Norovirus 
outbreaks between 1992 and 2000 in England & Wales revealed a similar situation. In total, 
40% of the outbreaks occurred in hospitals, 39% in residential-care facilities, 8% in hotels, 
4%in schools, 6%were linked to food outlets and the remaining 4% occurred in other settings 
[3]. These proportions were confirmed in a further study for 2002 in England & Wales [19]. 
 
In our study, in only seven of the 54 outbreaks (13%) with a known infection route for 
noroviruses could a foodborne transmission have occurred. Outbreaks due to contaminated 
food and water vary from country to country. Finland reported 24%, The Netherlands 17%, 
Slovenia 14%, Spain, England & Wales 7% [4]. The predominance of the person-to-person 
transmission route (81% of all outbreaks with known transmission route) confirms the results 
of an English study, where a rate of 85% was found [3]. 
 
The three consecutive outbreaks in ski camps clearly demonstrated the epidemiological 
potential of Norovirus-contaminated environments. Earlier studies have clearly shown that 
Norovirus particles may keep their infectivity for lengthy periods [20–22]. For example, on 
carpets they stay infectious for up to 12 days [20]. Therefore, treatment of contaminated 
environments with an appropriate disinfectant (noroviruses are non-enveloped viruses) is of 
the utmost importance in halting the chain of infection [6]. Adequate treatment of 
contaminated clothes and linen, e.g. pillow covers, should also be performed [6]. Outbreaks in 
camps should generally be reported to the management of the establishments so that 
disinfection of the rooms can be organized. Waterborne outbreaks with noroviruses were 
shown to be associated with contaminated septic tanks, industrial water systems and 
swimming water as well as drinking water worldwide [23]. Two waterborne outbreaks 
occurred in Switzerland in 1998 and 1999 [6, 24, 25]. The first outbreak with 3500 cases was 
a result of a pump failure producing a spill of sewage into the groundwater [24], the second 
outbreak with 1400 cases occurred due to the use of contaminated and accidentally untreated 
surface water [6, 25]. In 2001, the probable waterborne outbreak described in the present 
study was registered. The most recent case occurred in 2002 in a ski region of the Swiss Alps. 
Here, 100–150 persons suffered from acute gastroenteritis during a period of 2 weeks. 
Noroviruses were detected in patient stool samples and investigations revealed that the 
drinking water system was contaminated by faeces from a sewage leakage [Schmid, H. 
(SFOPH), personal communication]. There is a strong tendency that such outbreaks in 
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Switzerland are most often the result of deficiencies in the infrastructure or in the water 
treatment process [6, 26]. 
 
In the previously reported banquet incident, various facts pointed to a foodborne scenario, 
however, a cohort study demonstrated that no association existed between consumed 
foodstuff and illness. The introduction of noroviruses into the setting by the young girl who 
was ill shortly before the banquet is a scenario often found in outbreaks, particularly in camps 
and nursing homes. The simplicity of transmission of noroviruses can be explained by the low 
infectious dose (10–100 particles) [6, 8], the effective transport of the agent by air after 
projectile vomiting of infected persons [6, 27] and by the prolonged shedding of viruses [6, 
8]. Because of the simple and rapid transmission of noroviruses from person-to-person, every 
patient has a literally inherent potential to initiate outbreaks, at least within his own family. 
Public health institutions in particular, have to account for this possibility. Due to modern-day 
travel, noroviruses can easily cross national borders as demonstrated by two recent studies 
[15, 28]. Furthermore, a US study demonstrated the global circulation of a single Norovirus 
strain [29]. 
 
The previously presented example of consecutive outbreaks in a hospital with an affiliated 
nursing home illustrates how important it is not only to perform tests to detect noroviruses but 
also to conduct phylogenetic analysis of Norovirus RT–PCR products. Together with the 
results of the epidemiological investigation, it was feasible to determine that the incident was 
not one protracted outbreak, as initially thought, but consisted of different autonomous 
outbreaks. This was also meaningful in terms of the quality evaluation of the accomplished 
outbreak management. A very similar situation was found in another hospital, where from the 
beginning of Gastroenteritis outbreaks due to Norovirus 7 November to the end of December 
2002, 130 persons (patients and staff) were affected by Norovirus infections. Nine Norovirus 
isolates from patient stool samples were phylogenetically analysed and again exhibited two 
different clusters. These clusters were allocated to patients that stayed locally and temporally 
on different floors and departments of the hospital (data not shown). It is also important to 
note that these hospital outbreaks all reflect the Norovirus situation in the community. In each 
hospital outbreak, a number of patients had acquired their infection outside the hospital, i.e. in 
the community. Thus far, there exists only one Swiss hospital outbreak which has been 
previously described; in March 2001 with 63 patients [30]. 
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Epidemiological profiling, also recommended by authors from the United States, is a strong 
tool to conduct a fast and first assessment of a suspected Norovirus outbreak scenario [31]. 
This is important because of the current lack of routine analysis for noroviruses in 
Switzerland. Furthermore, the rapid implementation of outbreak control measures, even prior 
to the confirmation of Norovirus infection, is crucial. 
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6.1 Abstract 
 
Reported here is an outbreak of gastroenteritis due to Norovirus infection that affected at least 
450 persons from nursing homes and similar institutions in Switzerland during and after an 
organised pilgrimage to Lourdes in France. The outbreak was characteristic of direct person-
to-person transmission, with the primary cases occurring in the hospital that harboured some 
of the pilgrims in Lourdes. 
 
6.2 Introduction 
 
In recent years, outbreaks of viral gastroenteritis due to human caliciviruses of the genus 
Norovirus (formerly called “Norwalk-like viruses”) have been increasingly recognised in 
Switzerland. The growing awareness of these pathogens can be attributed to advances made in 
detection methods for the identification and typing of noroviruses (e.g., reverse transcriptase 
polymerase chain reaction technology). Illness is characterised by acute onset vomiting and 
diarrhoea following an average incubation period of 12–48 h. The faecal-oral route has been 
described as the most common route of transmission, but the very low infectious dose of these 
pathogens (probably <102 viral particles) allows easy and rapid spread from person-to-person 
via droplets, fomites, or faecal contamination [1]. Noroviruses are not routinely searched for 
in clinical microbiology laboratories in Switzerland, and there is no obligation to report 
infections caused by this viral agent to a governing health agency. For this reason, the Swiss 
Federal Office of Public Health launched a project to investigate outbreaks in which a viral 
aetiology was suspected [2]. The present report describes the investigation of one such 
outbreak that occurred in spring 2002 in association with an organised pilgrimage to Lourdes, 
France. Epidemiological investigations in Switzerland were conducted by the Cantonal 
Laboratory Basel-Landschaft and those in Lourdes by the district health office (Direction 
Départementale des Affaires Sanitaires et Sociales des Hautes Pyrénées). 
 
6.3 Patients and Methods 
 
On 2 May 2002 the health authorities of a Swiss canton informed the Swiss Federal Office of 
Public Health of an outbreak of gastroenteric illness occurring in a nursing home (institution 
A). The outbreak was affecting elderly residents as well as nursing staff. The observed 
symptoms and the spread of the illness were similar to those of earlier outbreaks in similar 
Paper 4: Rapid propagation of NV illness following a pilgrimage 56 
 
settings caused by noroviruses. It very quickly became apparent that institution A was part of 
a much larger outbreak that included many similar institutions whose residents had 
participated in a pilgrimage to the city of Lourdes in France.  
 
For the epidemiological investigation of the outbreak, the following two case definitions were 
used: (i) a person who participated in the pilgrimage to Lourdes between 19 and 25 April 
2002 and who developed symptoms compatible with Norovirus-associated gastroenteritis 
either during the pilgrimage or within the 2-week period thereafter; (ii) a person who was a 
resident or employee of one of the institutions participating in the pilgrimage who developed 
symptoms compatible with Norovirus-associated gastroenteritis within 3 weeks following the 
return of the pilgrims. The main symptoms of Norovirus-associated illness were defined as 
projectile vomiting and/or diarrhoea, and constitutional symptoms including headache, 
nausea, myalgia, abdominal cramps and fever.  
 
The pilgrimage to Lourdes was undertaken by individuals from 29 different institutions, and 
they were transported on four special trains. Those pilgrims who needed constant medical 
care (n=119) travelled on the so-called “blue train”, together with accompanying medical 
personnel, and they arrived at their destination in the morning of 20 April. The 119 pilgrims 
from this train stayed at a pilgrim’s hospital, and 107 of them were assigned to the third floor. 
The 89 accompanying personnel remained responsible for the care of the pilgrims during the 
whole stay, but they were accommodated in nearby hotels. On 21 April, the first cases of 
gastroenteric illness appeared among the pilgrims on the third floor of the hospital, and 1 day 
later the first cases of illness occurred among the accompanying personnel. By the end of the 
stay in Lourdes on 24 April, the number of new cases had reached 69. Thirty-three of these 
individuals were pilgrims, all of whom had resided on the third floor of the host hospital, and 
36 were accompanying personnel, who had resided in hotels (Fig. 1). Despite frequent get-
togethers during the stay in Lourdes, no cases occurred among pilgrims residing on other 
floors of the hospital or among other hotel guests.  
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Figure 1. Epidemic curve of an outbreak of Norovirus gastroenteritis occurring in pilgrims 
and accompanying staff in Lourdes, France, in April 2002 
 
During the return journey, which began on 24 April, no additional cases of illness occurred 
among the persons on the “blue train”. On 25 April the pilgrims returned to their 29 different 
institutions of residence. During the following days, 11 (38%) of these institutions 
experienced new outbreaks of gastroenteric illness, amounting to more than 380 apparently 
secondary cases.  
 
Institution A was the most severely affected, with 47 cases occurring among 64 residents 
(73%) and 32 cases among 63 staff members (51%). The accompanying physician from 
institution A was in contact with vomiting patients on the “blue train” and fell ill the day after 
return. Three residents of institution A had been ill in Lourdes and had travelled on the “blue 
train”; two staff members who had close contact with these three patients after their return fell 
ill on 27 April. Over the following days, the illness spread epidemically within the institution 
(Fig. 2). The outcome was fatal in one patient who had a severe underlying disease. 
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Figure 2: Epidemic curve of an outbreak of Norovirus gastroenteritis in a nursing home 
(institution A) after the return of three residents from a pilgrimage to Lourdes, France, in 
April 2002 where they had an episode of gastroenteritis. The physician accompanying the 
residents of institution A was in contact with vomiting patients during the return journey by 
train on 24 April and became ill himself on the day after return. Two staff members who had 
been in close contact with three pilgrims after their return became ill on 27 April. 
 
In institution B a very similar outbreak pattern was recorded, with attack rates of 17% (38 
illnesses) occurring among residents and 11% (28 illnesses) among staff. Furthermore, nine of 
the affected staff members in institution B reported similar illnesses among their family 
members outside of the institutional setting; however, these probable tertiary cases were not 
followed up. The epidemic curve for institution B was very similar to that of institution A and 
is therefore not shown. No staff member was shared between institutions A and B.  
 
Six stool specimens from patients in institution A and six from patients in institution B, all of 
which had resulted negative for routine bacteriological tests, were further analysed using 
reverse transcriptase polymerase chain reaction at the Cantonal Laboratory Basel-Landschaft, 
which specialises in the diagnosis of noroviruses. The method used involves a genogroup-
specific reverse transcriptase polymerase chain reaction system for the detection of Norovirus 
GG II based on degenerate primers and located in highly conserved regions of the RNA 
polymerase [3]. It is part of the method used to detect noroviruses in water samples, which 
has been approved by the Swiss Federal Office of Public Health [4]. All 12 specimens were 
positive for Norovirus, and 11 of the strains could be sequenced. A comparison of these 11 
sequences with the DNA sequences publicly available in the GenBank database (National 
Center for Biotechnology Information, Bethesda, Md., USA) [5] showed 94% identity of all 
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sequences with “Norwalk-like virus NLV/Miami Beach/326/1995/US” (GenBank Accession 
No. AF414424). For the phylogenetic comparison of sequences, ClustalX 1.81, PAUP 4.0b10, 
EMBOSS matcher 2.0u4 and TreeView V1.6.6 were used. Among themselves, the 11 
Norovirus sequences showed 99.4% identity. Cross-contamination with the positive control 
used for testing was excluded. Displayed in Fig. 3 is the NJ-phylogram of the RNA 
polymerase sequence information of the 11 Swiss Norovirus isolates from institutions A and 
B (deposited in GenBank under Accession No. AY339133–AY339143) plus the reference 
sequences. One Norovirus sequence isolated from a primary case patient in Lourdes (A4), 
who normally resided in institution A, showed 100% identity with the Norovirus sequence 
from a later case occurring in institution A (A2) and 99.4% identity with the Norovirus 
sequence of a case from institution B (B2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Phylogram created using the Neighbour Joining method of analysis with RNA 
polymerase sequence information of Swiss Norovirus isolates form institution A (A1, A2, A3, 
A4, A8), from institution B (B1, B2, B3, B4, B5, B6), the used internal positive control (Pos) 
and sequences from GenBank (Haw: Hawaii Calicivirus HCU07611; Lords: Lordsdale virus 
X86557; Camb: Camberwell virus AF145896). The internal positive control (Pos) has a 96% 
sequence identity with NV/Westover/302/1994/US{AF414418}]) 
 
Through further epidemiological investigations, it could be ascertained that in the week before 
the arrival of the Swiss pilgrims in Lourdes, and also in the week of their stay, gastroenteric 
illnesses also occurred in groups of French pilgrims. In the week following the departure of 
the Swiss pilgrims, 75 further cases of gastroenteric illness were recorded in the pilgrim’s 
hospital, with most of them occurring again on the third floor. 
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6.4 Discussion 
 
Many outbreaks due to Norovirus infection have been investigated in Switzerland in past 
years, and most of them showed an epidemic curve characteristic of a protracted outbreak 
with primary, secondary, and sometimes tertiary cases. In most of these events, the sequence 
of illness onset observed in the affected persons provided evidence for the direct transmission 
of a Norovirus from person to person [2], with foodstuffs or water being implicated in only a 
few instances. The outbreaks occurred in institutional settings (e.g. nursing homes, nursery 
schools, youth centres, hostels) or places where many people gather (e.g. sports events, youth 
camps, parties). Similar settings for Norovirus outbreaks have been described in other 
countries [6, 7, 8]. There is accumulating evidence that person-to-person transmission is the 
most common route of Norovirus infection [9, 10].  
 
In summer 2000, a Norovirus outbreak affected about 120 attendees of a boy scout camp in 
southern Switzerland. The index case had vomited prior to his arrival in the camp, while 
travelling by train. When the children returned to their homes in the northern part of the 
country, they caused new outbreaks among their family members [11]. A very similar pattern 
was observed in the pilgrimage outbreak described here, demonstrating again the highly 
infectious nature of noroviruses.  
 
The very close similarity (99.4%) determined in the viral sequences of strains from two 
different institutions pointed to a common origin of infection. The primary infections were 
probably acquired in the pilgrim’s hospital in Lourdes. However, it could not be conclusively 
determined whether the viral agent had been carried to the centre by visitors preceding the 
Swiss group or if a Swiss passenger on the “blue train” had been ill before the journey and 
was still shedding the virus while travelling. Due to the 100% identity shared by one 
Norovirus sequence isolated from a primary case in Lourdes, who normally resided in 
institution A (A4) and a Norovirus sequence from a later case occurring in institution A (A2) 
and the 99.4% identity shared by sequences from secondary cases in institution A (A2) and 
institution B (B2), it is very likely that returning virus shedders had caused secondary cases in 
their institutional settings. Patients in nursing homes and similar institutions can be regarded 
as particularly susceptible collectives.  
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This report clearly emphasises the importance of sequencing Norovirus isolates in outbreak 
investigations, since, in most instances, an epidemiological link between outbreaks is not as 
obvious as in the present case. Furthermore, it is hoped that this report may stimulate 
discussions in Switzerland regarding the need for an obligatory reporting system for 
Norovirus infections to ensure the future detection of linked outbreaks. 
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7.1 Summary 
 
Reported here are firstly the results of the phylogenetic analyses of human Norovirus (NV) 
isolates obtained from patients with sporadic infections and from outbreak cases in 
Switzerland between January 2001 and July 2003. Secondly, the results of the phylogenetic 
comparison between NV sequences from human stool specimens from Switzerland with NV 
sequences obtained from a recent study with European mineral waters and from an oyster 
screening in Switzerland (oysters originating from France) are presented. 63 of the 74 (85%) 
analysed human NV sequences belonged to NV Genogroup II and a temporal clustering was 
observed. The phylogenetic comparison of NV sequences from mineral waters and oysters 
with such of human origin revealed that the mineral water sequences were highly related and 
clustered predominantly separate to the human NV sequences. However, human NV 
sequences were also found within the mineral water cluster. Additionally, a temporal 
correlation between the dates of the stool specimen with the period of bottling of the mineral 
waters was observed. The oyster sequences displayed a far greater variability and no specific 
clustering with either mineral water or human NV sequences was found. 
 
7.2 Introduction 
 
Recent international studies have shown that viral infections, especially noroviruses (NV) 
(former name “Norwalk-like viruses”) are the most frequent cause of gastroenteritis in the 
community regarding the endemic and the epidemic situation (1-6). These viruses account for 
an estimated 6% and 11% of all infectious intestinal diseases in England and the Netherlands 
(3,5), respectively and for an estimated 23 million cases in the United States each year (7). 
NV are also the most common cause of outbreaks of infectious intestinal diseases in Western 
Europe and North America (3,7). The illness is characterised by acute onset of vomiting and 
diarrhoea, after an average incubation period of 12-48 hours. The faecal-oral route is 
described to be the most common route of transmission. NV are transmitted either by 
contaminated fomites (such as food and water) and environment, or directly from person-to-
person (8). Furthermore, outbreaks have been associated with the ingestion of contaminated 
drinking or recreational surface water (9). Two recent Swiss studies found RNA sequences of 
NV in bottled mineral waters of various brands (9-10). In one of these investigations, samples 
of three European brands of mineral water without gas were monitored by RT-PCR during a 
period of a year. NV sequences were detected in 33% (53 of 159) of the analysed samples (9). 
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A further monitoring study found that 8 of 87 samples of oysters (originating from France) 
(9%) imported into Switzerland were positive for NV (11). Reported here are the results of 
the phylogenetic analyses of Swiss human NV isolates obtained from January 2001 to July 
2003 and the results of the phylogenetic comparison between these human isolates with NV 
sequences from the mineral waters and oysters. 
 
7.3 Methods 
 
NV samples 
NV-positive stool samples were obtained from sporadic cases and from NV outbreak patients 
between January 2001 and July 2003. Stool samples were randomly chosen from all available 
patient samples. Sequence information from a monitoring of oysters (November 2001 to 
February 2002; used NV sequences isolated from French oysters) (11) and from a monitoring 
of three European brands of mineral water (April 2000 to April 2001) (9) were included in the 
phylogenetic comparison. 
 
RT-PCR methodology, sequence analyses and phylogeny 
All samples were analysed with the same NV RT-PCR methodology. The method used 
consisted of a genogroup-specific RT-PCR system for the detection of NV GGII based on 
degenerate primers, located in highly conserved regions of the RNA polymerase (system B) 
and of a second generic RT-PCR system also based on degenerate primers (system A) (12). 
This combined system is a part of the detection method for NV in water samples 
recommended by the SFOPH in Switzerland (13). The NV RT-PCR of the human stool 
samples was performed at the Cantonal Laboratory Basel-Landschaft and the sequencing of 
the RT-PCR products was carried out by Microsynth GmbH (9436 Balgach, Switzerland). 
Phylogenetic analyses were performed on sequences from both NV detection systems. 
Alignment of the sequences was conducted by the software ClustalX 1.81. The distance-based 
(Kimura matrix) neighbor-joining (NJ) method in the software package PAUP 4.0b10 was the 
algorithm used for analysis and the phylogenetic trees were constructed with the software 
Treeview 1.6.6. The robustness of the NJ-trees generated were assessed by bootstrapping 
(1000 replications) in PAUP 4.0b10. Pairwise sequence comparisons were carried out with 
the software EMBOSS matcher 2.0u4s. The strains found in this study were compared with 
the following published reference sequences (GenBank accession numbers in parentheses): 
Desert Shield Virus (DSV; U04469), Bristol Virus (BV; X76716), Camberwell Virus (CAV; 
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AF145896), Hawaii Virus (HV; U07611), Lordsdale Virus (LV; X86557), Melksham Virus 
(MKV; X81879), Mexico Virus (MXV; U22498). 
 
7.4 Results 
 
Phylogenetic comparison of Swiss human NV isolates 
In total, 74 NV sequences isolated from human stool samples were phylogenetically analysed. 
32 isolates were detected by the generic primer system (system A) and the other 42 isolates by 
the GGII – specific system (system B). The appropriate NJ-trees are plotted in the figures 1 
and 2.  
 
A region of the RNA polymerase of approximately 120bp was amplified by RT-PCR and 
used for the phylogenetic analysis in the NV generic system A. Three distinct sequence 
clusters were detected. Cluster I revealed an overall sequence identity of 76.0% in respect to 
the sequence “A08” and of 77.9% in respect to the GGI reference strain Desert Shield Virus 
(DSV). Cluster II showed an overall sequence identity of 83.9% compared to the sequence 
“A09”. The isolates within Cluster II grouped together with the following GGII reference 
strains: Hawaii Virus (HV), Camberwell Virus (CAV), Bristol Virus (BV), Lordsdale Virus 
(LV), Mexico Virus (MXV) and Melksham Virus (MKV). The isolates from cluster II showed 
an overall sequence identity of 85.0% with the Camberwell Virus. Finally, cluster III exposed 
a high sequence identity of 97.4% to the sequence “A30”, as seen in figure 1. 
 
For the NV GGII – specific system B, another region of the RNA polymerase of about 120bp 
was amplified by RT-PCR and used for the phylogenetic analysis. Two distinct clusters 
within NV GGII were found, as seen in figure 2. Cluster I showed an overall sequence 
identity of 96.1% compared to the sequence “B44” and cluster II demonstrated an overall 
sequence identity of 97.4% with the sequence “B43”. Cluster II included the reference strain 
Bristol Virus (BV) and Lordsdale Virus (LV). The sequence identity between “B43” and 
“B44” was 80.0%. Compared to the reference sequence of the Camberwell Virus (CAV), 
cluster I showed a sequence identity of 87.4% and cluster II an identity of 91.1%. 
 
In total, 11 of the 74 sequenced NV isolates (15%) belonged to the Norovirus GGI and 63 
samples (85%) to GGII. No local clustering of the patients where the NV sequences were 
derived from could be observed (data not shown). Interestingly, a temporal clustering of the 
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NV sequences was observed: 8 of 10 NV GGII samples from the year 2001 and detected by 
the system B could be assigned to the found cluster I, as seen in figure 2. The cluster II on the 
other hand is mainly formed by sequences obtained in the year 2002 (17 of 26) and in the 
early months of 2003 (8 of 26). Of further interest is the fact that all samples positive for GGI 
were only found in the year 2001 and in the early months of 2002 by the system A, as seen in 
figure 1. This corresponds to the observation that GGI isolates are hardly found in 
Switzerland since the middle of 2002 (data not shown). The NV sequences “A08”, “A09”, 
“A30”, “B43” and “B44” were submitted to GenBank (GenBank accession numbers: 
AY545060-AY545064). 
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Figure 1: NJ-tree showing the phylogenetic relationship between human NV sequences from 
Switzerland (generated with the generic RT-PCR system A) in comparison with the following 
reference strains: Desert Shield Virus (DSV; U04469), Bristol Virus (BV; X76716), 
Camberwell Virus (CAV; AF145896), Hawaii Virus (HV; U07611), Lordsdale Virus (LV; 
X86557), Melksham Virus (MKV; X81879), Mexico Virus (MXV; U22498). Bootstrapping 
values are indicated above the major branches. The sequence IDs are describing the used 
primer system [A], ID-number and date of illness [mmyy]. A contamination with the used 
positive control (“APos”) can be excluded. 
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Figure 2: NJ-tree showing the phylogenetic relationship between human NV sequences from 
Switzerland (generated with the NV GGII – specific RT-PCR system B) in comparison with 
the following reference strains: Bristol Virus (BV; X76716), Camberwell Virus (CAV; 
AF145896), Hawaii Virus (HV; U07611), Lordsdale Virus (LV; X86557), Mexico Virus 
(MXV; U22498). Bootstrapping values are indicated above the major branches. The sequence 
IDs are describing the primer system used [B], ID-number and date of illness [mmyy]. A 
contamination with the used positive control (“BPos”) can be excluded. 
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Phylogenetic Comparison between NV isolates from human stool samples from 
Switzerland, European mineral waters and French oysters 
 
Sequence data from 18 additional NV patients from Switzerland, collected between 1999 and 
spring 2001, were added to the 74 human NV isolates of the period between January 2001 and 
July 2003. With this completion, the underrepresentation in the number of NV sequences 
from spring 2001 and before was corrected. This was meaningful in respect to the date of the 
NV analyses with mineral water samples which started in April 2000 and lasted to April 2001. 
The NV analyses with the oyster samples were originally performed between November 2001 
and February 2002. Although the same NV RT-PCR method was applied on all samples, only 
a fragment of approximately 90bp for system A, respectively a fragment of approximately 
70bp for system B, could be used for phylogeny. Even if the complete sequence information 
(120bp for the human isolates, 150bp for the mineral water isolates and 140bp for the oyster 
isolates) were used for an improper phylogenetic comparison due to massive sequence 
overlaps, the main conclusions drawn on the following phylogenies remain the same (data not 
shown). 
 
Figure 3 shows the results of the phylogenetic comparison based on the system A. All NV 
sequences obtained from European mineral waters (IDs “ABAG#”) clustered entirely together 
in GGII and were distinct from all others except for one Swiss human NV sequence, 
“AAdd1”, which clustered within the mineral water sequences. This additional sequence 
derived from a NV positive tested water sample belonging to an outbreak in July 2000. The 
French oyster isolates (IDs “A60623” and “A54818”) clearly clustered separately form the 
human isolates and showed the highest relation to the reference sequences of Bristol Virus 
(BV) and Lordsdale Virus (LV), respectively to Melksham Virus (MKV). In figure 4, the 
results of the phylogenetic comparison within system B are presented. The majority of all 
sequences was very closely related. Remarkably, the European mineral water sequences were 
once more clustering together and closely related to Swiss human NV isolates (especially to 
“BAdd9”, “BPos” and “BAdd10”), whereas the sequences of the French oyster isolates were 
spread over the whole phylogram and showed no distinct clustering. The following NV 
sequences were submitted to GenBank: “AAdd1”, “BAdd9”, “BPos” and “BAdd10” 
(GenBank accession numbers: AY545065-AY545068). 
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Figure 3: Legend on page 73. 
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Legends of figures 3 and 4 
Figure 3: NJ-tree showing the phylogenetic relationship between human NV sequences from 
Switzerland (generated with the generic RT-PCR system A) in comparison with the sequences 
obtained from European mineral waters (“ABAG#”; indicated by black vertical bars) analysed 
between April 2000 and April 2001 and from French oyster samples (A60623 and A54818; 
indicated by black vertical bars) analysed between November 2001 to February 2002 and with 
the following reference strains: Desert Shield Virus (DSV; U04469), Bristol Virus (BV; 
X76716), Camberwell Virus (CAV; AF145896), Hawaii Virus (HV; U07611), Lordsdale 
Virus (LV; X86557), Melksham Virus (MKV; X81879) and Mexico Virus (MXV; U22498). 
Bootstrapping values are indicated above the major branches. The sequence IDs of the human 
samples are describing the primer system used [A], ID-number and date of analysis [mmyy]. 
 
Figure 4: NJ-tree showing the phylogenetic relationship between human NV sequences from 
Switzerland (generated with the NV GGII – specific RT-PCR system B) in comparison with 
the sequences obtained from European mineral waters (“BBAG#”; indicated by black vertical 
bars) analysed between April 2000 and April 2001 and from French oyster samples 
(“B60623” and “B54818”; indicated by black vertical bars) analysed between November 2001 
to February 2002 and with the following reference strains: Bristol Virus (BV; X76716), 
Camberwell Virus (CAV; AF145896), Hawaii Virus (HV; U07611), Lordsdale Virus (LV; 
X86557) and Mexico Virus (MXV; U22498). Bootstrapping values are indicated above the 
major branches. The sequence IDs of the human samples are describing the primer system 
used [B], ID-number and date of analysis [mmyy]. 
 
7.5 Discussion 
 
Phylogenetic comparison of Swiss human NV isolates 
15% (11 of 74) of the NV isolates from human stool samples obtained between January 2001 
and July 2003 were allocated to the NV GGI, the remaining 85% (63 of 74) NV isolates to the 
NV GGII. Furthermore, temporal clustering within the sequences could be observed. All GGI 
isolates were found in the year 2001 and early months of the year 2002 (figure 1). Analyses of 
the NV isolates detected by the GGII – specific system B showed that 8 of 10 NV isolates 
from the year 2001 grouped together and that 23 of 26 isolates from the year 2002 and early 
months of 2003 clustered jointly (figure 2). The temporal dominance of different NV strains 
or genotypes is described in various studies. A review of the internationally available NV 
sequences between the years 1992 and 2002 revealed a clear dominance of GGII strains and 
genotypes from both sporadic cases and outbreaks and the cyclic emergence and 
disappearance of distinct NV strains (14-21). A well cited study showed that a subset of 60 
strains, the so-called ”95/96-US” strain (GGII), was predominantly associated with NV 
outbreaks during the 1995-1996 season in the US. Furthermore, this strain showed a global 
distribution (15,18). In Europe, it could be observed that NV sequences found in the years 
2000 and 2001 clustered around a newly emerging variant of a GGII strain (so-called 
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“GGIIb” strain) (19-20). Likewise, a cluster of NV isolates around a new GGII/4 strain (so-
called “Farmington Hills” strain) could be detected during the year 2002 in the US (21). A 
striking increase in NV outbreaks occurred in 2002 in England and Wales, Germany, and in 
The Netherlands. This coincided with the emergence of a new predominant NV GGII/4 
variant (22). In the GGII – specific system B 23 of 26 NV isolates from the year 2002 and 
early months of 2003 were clustering together. Within this specific cluster, Bristol virus, a 
GGII/4 reference strain (23) can be found (figure 2, cluster II). Most probably, these NV 
isolates are therefore corresponding to the new variant found in Europe. This assumption 
seems to be reasonable, because of the first occurrence of these new variant in Germany 
(Switzerland lies next to Germany) in January 2002 (22). Furthermore, a Swiss NV screening 
study from July 2001 to July 2003 revealed that the detection rates of NV positives peaked 
between January and July 2002 (manuscript in preparation). This circumstance may explain 
the grouping of certain NV GGII sequences found in this study. 
 
Phylogenetic comparison between NV isolates from human stool samples from 
Switzerland, European mineral waters and French oysters 
Phylogenetic analyses with both systems (NV generic system A and NV GGII – specific 
system B) revealed similar results with respect to the NV sequences from the European 
mineral water samples (figures 3 and 4). All mineral water sequences were highly related and 
clustered predominantly separate to the human NV sequences. Nevertheless, single human 
NV isolates from Switzerland were also found within these mineral water clusters. 
Furthermore, it was shown that the NV sequences found during the mineral water screening 
from April 2000 to April 2001 (9) were closely related to human NV isolates. The analysed 
European mineral waters were all bottled between October 1999 and August 2000. 
Interestingly, Swiss human NV isolates clustering within the European mineral water 
sequences (“AAdd1”, “BAdd9”, “BPos” and “BAdd10”) came from patients of the same time 
period. From an epidemiological point of view, the NV positive results obtained by RT-PCR 
of mineral waters have to be treated with caution because the used detection method is not 
able to distinguish between infective and inactivated virus (9,10,24). But it was demonstrated 
that the NV sequences from the analysed mineral waters were stable after 6 and 12 months of 
storage (9). Furthermore, a recent study could display that enteric viruses, inactivated at 
moderate temperatures, still have a capsid that protects the RNA from RNase (25). The origin 
of NV sequence contamination in bottled mineral waters also remains unclear. Water sources, 
packing materials or the bottling process were considered as possible origin of contamination 
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(9). Contamination of the water source, e.g. by surface waters, may play a role. If so, could 
NV derive from an animal reservoir ? This way can be excluded because to date, no zoonotic 
transmission of NV was demonstrated (26). Additionally, it is established that the NV strains 
in animals (calf and pig) were genetically distinct to any NV found in humans (26-28). 
Regarding the close relationship between NV sequences found in mineral waters and human 
stool samples, it can be stated that the detected NV in the mineral waters are of human origin. 
The sensitivity of the method used was estimated to be around 10 viral particles. This 
suggested a low concentration of NV sequences per litre of the tested mineral water brands 
(9). Additionally, a case-control study to investigate risks for NV infections did not identify 
mineral waters to be a measurable risk factor (manuscript in preparation). Therefore, it can be 
supposed that mineral waters do not play a relevant role in the epidemiology of NV in 
Switzerland. This estimate confirms a former assessment of the Swiss Federal Office of 
Public Health (SFOPH) (6). 
 
The sequence analyses NV from the French oysters showed a far greater variability compared 
to the NV sequences generated from the mineral water samples. Oyster sequences were not 
found within specific clusters, but grouped together with NV sequences from mineral waters 
and human samples. Together with the low NV positivity rate of 9% (8 of 87 samples) of the 
oyster monitoring study (11) and since the overall consumption of oysters in Switzerland is 
rather low (11), the direct impact on food safety and the epidemiology of the NV can be stated 
as rather low. 
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8. Discussion and Conclusions 
 
8.1 General Considerations 
 
The present thesis was launched in the second half of the year 2000. Since then, the awareness 
of the relevance of NV infections has risen worldwide, especially in high-income countries. 
Prior to these studies, little epidemiological data was available for an assessment of the 
situation of the NV in Switzerland. Single incidents of foodborne NV outbreaks (25 
confirmed or possible NV infections) were reported to the Swiss Federal Office of Public 
Health (SFOPH) between 1993 and 1998 (1). Between 1999 and 2000 “several outbreaks due 
to Norwalk-like viruses” were recorded (2). In March 2000, a pilot study was carried out by 
the Cantonal Laboratories Solothurn and Basel-Landschaft. This study revealed that 44 of 100 
stool samples previously analysed negative for enteric bacterial and parasitic pathogens were 
NV-positive by RT-PCR (3). This result – together with the realisation of a gap in 
epidemiological data concerning NV – lead to the carrying out of the present studies. In the 
next sections, the methodology, the different study designs and the key results from these 
studies will be reviewed and a final conclusion concerning the present NV situation in 
Switzerland will be drawn. 
 
8.2 RT-PCR Methodology and Phylogenetic Analysis 
 
Using sequence information derived from an increasing number of NV strains, several 
international research groups successfully developed RT-PCR assays – similar to the one 
adopted in the present study – based on primers targeting a conserved region of the open 
reading frame 1 (ORF1) coding for the viral RNA polymerase. These assays have been used 
successfully in epidemiological studies for the diagnosis of NV in faecal specimens from both 
outbreaks and sporadic cases (4). A crude estimation of sensitivity of the used RT-PCR 
system was carried out and found to be approximately 10 NV particles in water samples (5). 
However, there is no data about sensitivity and specificity concerning the detection of NV in 
stool samples, a matrix far more complex than drinking water. Based on the high number of 
virus particles found in stool specimens (approximately 107 particles per ml) (6), the 
sensitivity of this assay may be nevertheless compromised by the possible occurrence of 
inhibitors effecting the PCR. Concerning the ability to detect current NV strains circulating in 
the population, it can be stated that the assay covered at least a great number of strains 
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circulating between 2000 and 2003 in Switzerland. This can be explained firstly by the 
creation of the assay in 1999 and its first use in 2000 (7) and secondly by the ability to detect 
sequences that belong to the newly emerged variant of NV as described in chapter 7. 
 
8.3 Study Designs 
 
NV Screening 
From July 2001 to July 2003, a screening for the presence of NV in previously 
bacteriological-negative tested stool samples (negative at least for Campylobacter spp., 
Shigella spp. and Salmonella spp.) has been undertaken. The NV analysis was conducted on 
stool samples from patients that had to fulfil specific criteria, like age constraint (patients only 
between 6 months and 75 year of age) and the exclusion of known outbreak and hospital 
cases. The frequency of NV-positive stool samples was influenced by several selection biases 
introduced e.g. by the stringent inclusion criteria and by the local dominance of patients from 
cantons within the northern and the central part of the study area. A recent study revealed 
valuable information about possible selection biases concerning the presentation of cases of 
diarrhoea to general practice (GP) (8). The most relevant results from the present study were 
that severe illness, recent foreign travel, leaving full-time education at an early age and 
housing conditions (representing lower socio-economic status) all were associated with GP 
presentation (8). A further selection bias was brought into the study by the circumstance that 
parallel to the screening a case-control study was performed on the patients. From these 
patients, an informed consent prior to the NV analyses had to be obtained. Therefore, it is 
obvious that the NV positivity-rate may not be extrapolated from the study population to the 
general population. Nevertheless, this screening was very valuable to generate a baseline of 
the occurrence and distribution of NV infections in patients suffering from gastrointestinal 
illness or disorder. 
 
NV Case-Control Study 
A general practitioner-based matched case-control study was performed between July 2001 
and July 2003. NV patients were identified by collaboration with two medical diagnostic 
laboratories and cases had to fulfil the following case definition: 1.) Episode of diarrhoea 
and/or vomiting in patients consulting a medical practitioner in the study area. 2.) Stool 
sample tested negative at least for Campylobacter spp., Shigella spp. and Salmonella spp. 3.) 
Stool sample tested positive for NV by RT-PCR. 4.) Cases residing within the defined study 
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area. 5.) Only one case per family was allowed to take part in the study. Furthermore, the 
following exclusion criteria applied: Babies under the age of 6 months, elderly patients above 
75 years, patients with a history of possible nosocomial disease and known cases from an NV 
outbreak. One “friend-control” per case was selected. The control had to be of the same sex, 
to belong to the same age group and was not allowed to be related with the corresponding 
case. In addition, the control had to live at a close range to the case. Unfortunately, the use of 
a “friend-control” introduces automatically an unplanned matching, because it is likely that 
the case and his friend (control) share many lifestyle characteristics (9). 
 
In total, 126 patients and 76 control persons were approved for the study. In comparison with 
other European case-control studies on gastrointestinal illness this sample size is relatively 
low. For example, the case-control component within the British “Study of Infectious 
Intestinal Disease in England” between 1992 and 1996 (10) was performed on over 1300 
matched case-control pairs, a French study carried out in 1997 (11) recruited over 560 
matched case-control pairs and finally a Dutch study was carried out with 878 cases and 581 
controls (12). There exists one recent case-control study with a comparable number of 
participants (152 matched pairs), where all the persons were recruited from an antecedent 
large cohort study (13). The initially goal of 190 case-control pairs in the present study (as 
considered sufficient for detection of an OR 2.0 by sample size calculations prior to the study) 
could not be achieved. This can be explained by the circumstance that the overall positivity-
rate within the screening (where cases were recruited from) was lower than the initially 
though 40%, obtained during the pilot study in March 2000 (3). Consequently, the through-
put of NV-analyses of stool samples would have been increased which was impossible due to 
limitations of financial and human resources. 
 
Cases and controls were matched for sex, age and domicile. The characteristics most 
appropriately specified for matching are those that are potential confounders of the exposure-
disease association. Reflecting the present study, only the matching on age was really 
necessary because of the uneven distribution of risk for NV illness regarding age groups (14). 
Therefore, besides the appropriate matched analysis by logistic regression, the matched pairs 
were broken and analysed by using a random effects logistic regression. The latter procedure 
allowed the inclusion of all the data, including those of cases with no corresponding control. 
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The self-administered questionnaires obtained demographic information and contained 
questions on the date of onset and the nature of symptoms (cases only), date of inquiry and 
further factors considered relevant for the disease under study (e.g. consumed food items and 
beverages, travel history, contact to ill persons etc.). Although the questionnaire was designed 
primarily on issues of food consumption because at that time the foodborne spread was 
thought to be the predominant transmission mode. This was then supported by the estimation 
of the US Centers for Disease and Prevention (CDC) that 39% of all NV outbreaks registered 
in the US between 1996 and 2000 happened due to foodborne transmission (6). This 
assessment heavily influenced the complete design and direction of the used questionnaire. 
Nevertheless (and luckily), the questionnaire allowed to gather at least some important 
information about the relevance of the person-to-person spread. Copies of questionnaires are 
available upon request. 
 
NV Outbreak Investigations 
Between 2001 and 2003, an inter-cantonal network in the German speaking part of 
Switzerland was established. Integrated were initially the cantonal laboratories and cantonal 
surgeons and all investigations were done in accordance with the SFOPH. Very soon this 
network became more a web of flow of information concerning various questions about NV-
associated illness. Within this great cooperation, several institutions and persons other than 
cantonal health authorities were involved (like medical laboratories, physicians, infection 
nurses, directors from nursing homes etc.). With this background, NV outbreak information 
were compiled on the one hand systematically by the cooperation with the health authorities 
and on the other hand information was collected very stochastically by attaining information 
from the different participants of the network. One of the advantages of this web of 
information was that many different outbreaks regarding the number of ill persons and 
settings were recorded, starting by family outbreaks of three persons, going further to hospital 
outbreaks and ending by a pilgrimage where NV incidents must be seen in an international 
context. But, the most inherent characteristic of this network was its temporality. Mainly 
because of the possibility to offer NV analyses on patient and environmental samples and the 
carrying out of outbreak investigations at no charge. With the ending of this three year’s 
cooperation, it must be assumed that the number of registered NV outbreaks will decrease. 
Mainly because of the ending of this ‘epidemiological service’ and because of the lack of a 
mandatory reporting of known NV cases (apart from the obligatory reporting of outbreaks 
registered by the cantonal health authorities, Epidemiengesetz SR 818.101). 
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In total, 73 NV outbreaks were registered within three years. But it has to be pointed out that 
90% of the registered incidents happened in the German speaking part of Switzerland. Most 
NV outbreaks within the French and the Italian speaking part of the country have not been 
recorded at all.  
 
8.4 Results of the Studies 
 
This section covers only the main outcomes and reference should be made to the single 
discussion chapters within the papers. 
 
8.4.1 Results of the NV Screening and of the Phylogenetic Analysis of NV Isolates 
obtained from Human Stool Samples 
 
A striking increase in NV outbreaks in Europe and in the US occurred in 2002. This coincided 
with the emergence of a new predominant NV GGII/4 variant (15-16). Furthermore, US data 
from 1995–1997 suggested also the emergence of a globally common strain that accounted for 
55% of all Norovirus outbreaks investigated by the CDC during that period. Like the newly 
emerging strain in 2002, the “common strain” of 1995–1997 was also classified as a GGII/4 
strain (15). In the present NV screening (see chapter 3) the highest rate of NV-positives was 
observed in the first quarter of the year 2002 and corresponds exactly to the first appearance 
of the new NV variant in Germany in January 2002 (16). This estimation is supported by the 
results of the phylogenetic comparison of NV isolates from Swiss human stool samples (see 
chapter 7). It was shown that 23 of 26 NV isolates from the year 2002 and early months of 
2003 clustered together and around Bristol virus, a GGII/4 variant. The dramatic decrease of 
50% in the NV positivity-rates from the first year (July 2001 to July 2002) to the second year 
(July 2002 to July 2003) under study may be reflected by changes in the circulation of NV 
strains.  
 
But it must be pointed out that the overall rise in the number of recognised NV cases can 
certainly be co-explained by the recent rise in awareness of the public health institutions 
worldwide and by the broader implementation of molecular detection methods (17). The 
finding of the similarity within the age structure between NV-positive and NV-negative tested 
persons is remarkable. This can be explained that certain parts of the population (toddlers and 
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the elderly) were not included in the screening due to the case definition. Therefore, the 
expected accumulation of NV infections in these groups (18) could not be shown. 
 
A second screening revealed information about the possible relevance of NV mixed-
infections. Totally, 132 stool samples positively tested at least for one bacterial pathogen were 
analysed for the presence of NV and only in one specimen NV were detected. The only found 
mixed-infection was caused by NV and Salmonella enteritidis and the patient had a travel 
history to Greece. There are only few European studies on gastroenteritis where a broad panel 
of intestinal pathogens were tested by using recently developed techniques. During the 
conduction of a population-based prospective study on gastroenteritis in The Netherlands, 
more than one pathogen was found in 8% of all stool samples studied (19). Mixed-infections 
in a Dutch general-practice based case-study were detected in 2.3% of all patients (20). 
Compared to the present results, the Dutch studies showed a higher number of NV mixed-
infections. The discrepancy may be explained by the limitation that only bacteriologically-
positive stool samples were analysed for NV and by the exclusion of children under 2 years of 
age, who are often infected by Cryptosporidium sp. and rotaviruses. Nevertheless, the results 
from the present study suggest that NV mixed-infections are playing a marginal role in 
Switzerland. 
 
8.4.2 Assessment of Risk Information for NV Infection 
 
NV Transmission Routes 
Person-to-Person Transmission 
Two studies with the objective to collect information about risk factors for NV infections in 
Switzerland were conducted. A case-control study (see chapter 4) covered sporadic NV 
infections whereas the systematic outbreak investigations (chapter 5) revealed information 
from the epidemic situation. Both studies clearly showed the dominance of the person-to-
person transmission pathway. This finding is consistent with current knowledge (14,21). 
Further, results from the case–control study showed that a surprisingly large number of the 
originally thought ‘sporadic NV cases’ were truly belonging to determinable chains of 
infections. 39% of all cases reported had contact to ill persons before, respectively 33% after 
their own illness. At least the antecedent and the following case of acute gastroenteritis within 
a family or relationship strongly suggest a chain of infection. This kind of personal contacts 
within and outside the family has been shown as a relevant risk factor in earlier studies 
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(11,13). Probably, the effect of family-external contacts to ill persons were narrowed, because 
persons known to belong to a NV outbreak were excluded from the case-control study. 
Concerning the outbreak situation, the finding is similar: in 54 of the 73 registered NV 
outbreaks (74%) the transmission pathways were known and in 44 incidents (81%) the 
person-to-person transmission was found to be the primary infection route. 
 
Foodborne Transmission 
The case-control study covered questions about the consumption of a variety of foodstuff and 
beverages in relation to NV illness. But the consumption of salads, raw berries, tap water, 
mineral water and sweet beverages could not be associated with the NV gastroenteritis. 
However, due to the low sample size, risk associations smaller than OR 3.0 may not have 
been detected. But, it can be stated that the foodstuffs and the beverages in question may 
probably not exhibit a high risk for NV infection. This assessment is supported by the results 
of the outbreak investigations. In only 7 of the 54 outbreaks (13%) with known transmission 
routes, a foodborne spread was a possible reason for the outbreak. Generally, the registration 
of outbreaks due to contaminated foods and waters varies from country to country. Finland 
reported 24%, The Netherlands 17%, Slovenia 14%, Spain, England and Wales 7% (22). The 
predominance of the person-to-person transmission route (81% of all outbreaks with known 
transmission route) confirms the results of an English study, where a rate of 85% was found 
(21). 
 
Two recent Swiss studies found RNA sequences of NV in bottled mineral waters of various 
brands (5,7). In one of those screenings, samples of three European brands of mineral waters 
without gas were monitored by RT-PCR during a period of a year. NV sequences were 
detected in 53 of 159 samples (33%) analysed (5). A further monitoring study found that 8 of 
87 samples of oysters (9%) imported into Switzerland were positive for NV (23). The 
phylogenetic comparison between NV isolates from human stool samples, mineral waters and 
oysters (see chapter 7) revealed the following results: All mineral water sequences were 
highly related and clustered predominantly separate to the human NV sequences. 
Nevertheless, single human NV isolates were also found within these mineral water clusters 
and it can be stated that the NV sequences from the mineral waters were all closely related to 
human NV isolates. Interestingly, the human NV isolates clustering within the mineral water 
sequences were derived from patients of the same time period like the bottling of the mineral 
waters. 
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However, the NV positive results obtained by RT-PCR on mineral waters have to be treated 
with caution because the detection method used is not able to distinguish between infective 
and inactivated viruses. Additionally, the stability of NV sequences in mineral water was 
estimated. NV sequences were found after 6 and 12 months of storage of the mineral waters 
and this suggests a high stability of NV sequences (NV particles) in mineral water (5). The 
origin of NV sequence contamination in bottled mineral waters remains unclear. Three main 
contamination routes are considered: contamination of the water sources, of the packing 
materials or during the bottling procedure (5). Contamination of the water source, e.g. by NV 
contaminated surface water, may play a role. Regarding the close relationship between NV 
sequences found in mineral waters and human stool samples, it can be stated that the detected 
NV in the mineral waters are of human origin. The sensitivity of the method used was 
estimated to be approximately 10 viral particles. This suggests a low concentration of NV 
sequences per litre of the tested mineral water brands (5). Together with the mentioned results 
of the case-control study, it can be concluded that mineral waters are not playing a relevant 
role in the overall epidemiology of NV in Switzerland. This estimate confirms a former 
assessment of the SFOPH (17). 
 
The sequence analyses of oyster isolates, showed a far greater variability compared to the NV 
isolates derived from mineral water samples. Oyster sequences were not found within specific 
clusters, but grouped together with NV sequences from mineral waters and human samples. 
Together with the low NV positivity rate of 9% (8 of 87 samples) found in the originating 
oyster monitoring study and since the overall consumption of oysters in Switzerland is rather 
low (23), a direct impact on food safety and the epidemiology of NV might be rather low. 
 
Other Transmission Modes 
Two waterborne outbreaks occurred in 1998 and in 1999 in Switzerland (17,24-25). In 2001, a 
probable waterborne outbreak with more than 650 patients was registered and in 2002 the last 
possible waterborne outbreak with approximately 100-150 persons was recorded (see chapter 
5). Generally, there is a strong tendency that such outbreaks in Switzerland are most often the 
result of deficiencies in the infrastructure or in the water treatment process, e.g. the leakage of 
the sewage water system with consequent contamination of the drinking water system or 
deficiencies in the application of chlorine and/or ozone to the drinking water (3,17). 
Environmental contamination is a logical consequence due to heavy diarrhoea and projectile 
vomiting and to the high environmental stability of the viruses (17) and plays an important 
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role especially in prolonged and protracted NV outbreaks (26-28). The description of the three 
consecutive outbreaks in ski camps in 2001 in Switzerland (chapter 5) demonstrates clearly 
the importance of environmental contamination and the necessity of an appropriate cleaning 
and disinfection during and after an outbreak. 
 
In summary, the person-to-person transmission plays by far the most important role within 
outbreak settings and in sporadic NV infections. Waterborne transmissions occur and are 
mostly the result of ‘engineering problems’ and may result in a high number of cases. The 
foodborne transmission plays an important but not the major role in comparison to the overall 
epidemiology. But the key to all the different transmission pathways are always ill persons. 
To exemplify, at the beginning of every foodborne chain of infection stands a foodhandler 
infected with NV. Also oysters are contaminated by filtrating of sea water polluted by human 
faeces and consequently virus particles are accumulated in the oyster tissue (23,29). However, 
environmentally contaminated shellfish may introduce new strains to an area or cause 
infection with multiple strains thus providing the right circumstances for genetic 
recombination to occur (14). To date, no zoonotic transmission of NV was demonstrated and 
it could be shown that the NV strains in animals (calf and pig) were genetically distinct to any 
NV found in humans (30). 
 
Settings of NV Outbreaks 
 
A clear dominance of closed and semi-closed settings was observed within the 73 registered 
NV outbreaks. 25 (34%) outbreaks occurred in nursing homes and asylums for disabled, 18 
(25%) in hospitals and health resorts, 9 (12%) in school and boy scout camps, 6 (8%) at 
festivities, 5 (7%) in hotels, 4 (5%) in the community, 3 (4%) in military settings, 1 (1%) at a 
pilgrimage and 2 (3%) in other settings. These findings confirm the results of earlier studies, 
where a very similar distribution of outbreak settings was found (21,31). For a number of 
reasons, NV pose a particular health risk in hospitals and nursing homes. NV can be 
introduced into institutions by an ill patient or visitor from the community (often recognised 
in Switzerland), by food or water. Since living quarters in both nursing homes and hospitals 
are tight and personal hygiene may be reduced as a result of poor health or incontinence, 
conditions are prime for person-to-person transmission (14). The high attack rates (30-50%) 
found in NV outbreaks are not only limited to residents and patients. It is obvious that such 
high infection rates pose a real risk for maintaining the regular operation, e.g. of a nursing 
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home, during an outbreak. Of highest importance is a fast and accurate reaction in terms of 
outbreak control. A first assessment of a NV suspicious incident within a closed setting has to 
be done immediately, even prior to laboratory proof of NV infection. Only with a rapid 
response, outbreaks can be contained and the number of affected people controlled (17). 
 
High Infectivity of NV 
The outstanding high infectivity of the NV can be explained by a number of factors: By the 
low infectious dose of about 10-100 virus particles, by the high number of excreted viruses 
during the course of illness (approximately 107 particles per ml stool in the first days of 
illness), by the aerosolisation of the NV during the physical act of vomiting and by the high 
environmental stability (also against commonly used disinfectants) (17). The high infectivity 
is very descriptive explained in the case report of the propagation of NV through multiple 
nursing homes following a pilgrimage (see chapter 6). Further, this incident demonstrated 
very clearly how easy NV may be transmitted over longer distances and even across national 
borders. These characteristics emphasise the building of interregional or international 
networks such as the leading European Food-borne Viruses Network (16) 
 
8.5 Conclusion and Outlook 
 
It could be clearly shown that NV infections in Switzerland are an important issue in terms of 
public health. The NV screening revealed that a high number of infected persons per year 
must be anticipated. A first and very crude assessment of the SFOPH resulted in an estimate 
of approximately 400'000 NV cases per year in Switzerland (17). A recent study in The 
Netherlands found that the incidence of infectious gastroenteritis was determined to be 283 
cases per 1000 person-years. In the case-control component of the study, viral agents 
accounted for 34% of all cases, with NV the most common viral pathogen, accounting for 
11% of cases. (14). Similar, results from the England’s IID study revealed an overall rate of 
194 cases per 1000 person-years and the rate of NV infection was 13 cases per 1000 person-
years (6% of all cases) (19). In Germany, an incidence for NV infection based on the 
reporting system was found for the year 2002 to be 57 per 100'000 persons (32). Germany has 
introduced its NV-specific reporting system in 2001 (33). 
 
The high number of outbreaks registered (mainly from the German speaking part of 
Switzerland) with numbers of affected patients ranging from 3 to 650 per outbreak was really 
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outstanding and exceeded the expectations. It is obvious that within a closed setting, a fast and 
adequate outbreak controlling is absolutely indicated. Information about the correct outbreak 
measures have to be disseminated from the cantonal and federal health systems to the 
concerning closed and semi-closed institutions. 
 
The person-to-person transmission in comparison to the food- and waterborne spread was 
coming to the fore. This is truly an important conclusion and must be beard in mind especially 
during NV outbreaks. But the foodborne background must not be forgotten. As an example, 
the cantonal food inspectorates and its inspectors have to be informed about the NV and their 
epidemiological potential. On the other hand, the water industry must remain cautious about 
their quality of the treatment and processing of drinking water. The multiple waterborne 
outbreaks in the past have demonstrated the severe consequences of failures in the (drinking) 
water treatment. 
 
The recent reports on NV sequences in mineral waters have risen a lot of dust internationally. 
But bacterial and fungal contamination of bottled mineral waters have been reported 
repeatedly (5,34) which suggests that viral contamination is also possible. In the present 
phylogeny, it could be stated that the NV sequences are of human origin. However, the most 
crucial questions about the infectivity and amount of NV particles found in mineral waters 
must remain unanswered to date. However, with the state of today’s knowledge, the 
conclusion can be drawn that mineral waters contaminated by NV play not a relevant role in 
the overall epidemiology of NV in Switzerland. This estimate confirms the current assessment 
of the SFOPH.  
 
The future trend of the NV situation in Switzerland is unpredictable. Therefore, strategies 
have to be implemented by the health authorities to remain on track. Meanwhile, several 
medical laboratories have already implemented the NV detection methodology. With the 
broader application of NV analysis, it should be considered, if NV should be included in the 
laboratory-based mandatory reporting system in Switzerland. Germany may serve herewith as 
an example. Also, the future development and enhancement of alternative cost-efficient 
essays to the RT-PCR detection methodology (e.g. ELISA) should be followed. The recent 
(real-time) PCR protocols are fast and accurate but still very cost intensive. Further, the future 
trend concerning the outbreak situation is unknown and is most probably linked to the 
circulation of certain NV strains in the community and to the general awareness of the NV. 
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However, the next goal that has to be approached is the broad dissemination of information 
concerning the NV in Switzerland. A first step was taken by a recent publication in the 
Bulletin of the SFOPH (17). Following to this article, a national reference brochure on NV 
will be generated in 2004. This brochure will cover the biology, the epidemiology and the 
prevention of NV illness in Switzerland and should be propagated widely. This brochure 
should also serve as a guideline for an accurate reaction to NV illness and prevention of – or 
at least minimising – the spread of infection. 
 
Finally, it can be concluded that although the results of the recent methodological and 
epidemiological studies have allowed to catch up with the current situation of the NV in 
Switzerland, the future development in this field has to be closely observed. 
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Annex SFOPH Reporting Form: 
“Gehäufte Fälle von Erkrankungen mit gastrointestinalen Symptomen” 
 
It would be very appreciated if any accumulated cases of gastrointestinal illness or disorder 
would be optionally reported to the Swiss Federal Office of Public Health (SFOPH). The 
reporting form may be downloaded in German or in French from the following website: 
http://www.bag.admin.ch/infreporting. 
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